<!DOCTYPE html>
<!-- saved from url=(0095)https://web.archive.org/web/20221028221515/https://baike.sogou.com/kexue/d18154930745377030.htm -->
<html class="" data-reactroot=""><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><script src="./d18154930745377030.缺氧诱导因子 - 搜狗科学百科_files/analytics.js.download" type="text/javascript"></script>
<script type="text/javascript">window.addEventListener('DOMContentLoaded',function(){var v=archive_analytics.values;v.service='wb';v.server_name='wwwb-app223.us.archive.org';v.server_ms=217;archive_analytics.send_pageview({});});</script>
<script type="text/javascript" src="./d18154930745377030.缺氧诱导因子 - 搜狗科学百科_files/bundle-playback.js.download" charset="utf-8"></script>
<script type="text/javascript" src="./d18154930745377030.缺氧诱导因子 - 搜狗科学百科_files/wombat.js.download" charset="utf-8"></script>
<script type="text/javascript">
  __wm.init("https://web.archive.org/web");
  __wm.wombat("https://baike.sogou.com/kexue/d18154930745377030.htm","20221028221515","https://web.archive.org/","web","/_static/",
	      "1666995315");
</script>
<link rel="stylesheet" type="text/css" href="./d18154930745377030.缺氧诱导因子 - 搜狗科学百科_files/banner-styles.css">
<link rel="stylesheet" type="text/css" href="./d18154930745377030.缺氧诱导因子 - 搜狗科学百科_files/iconochive.css">
<!-- End Wayback Rewrite JS Include -->
<meta name="save" content="history"><meta http-equiv="X-UA-Compatible" content="IE=edge"><meta name="baidu-site-verification" content="VWGb6TyYx8"><meta content="缺氧诱导因子 - 搜狗科学百科" name="keywords"><meta content="搜狗科学百科是一部有着平等、协作、分享、自由理念的网络科学全书，为每一个互联网用户创造一个涵盖所有领域知识、服务的中文知识性平台。" name="description"><meta http-equiv="x-dns-prefetch-control" content="on"><meta name="server" baike="235" ip="210" env="online"><link rel="dns-prefetch" href="https://web.archive.org/web/20221028221515/https://cache.soso.com/"><link rel="dns-prefetch" href="https://web.archive.org/web/20221028221515/https://hhy.sogoucdn.com/"><link rel="dns-prefetch" href="https://web.archive.org/web/20221028221515/https://pic.baike.soso.com/"><link rel="dns-prefetch" href="https://web.archive.org/web/20221028221515/https://ugc.qpic.cn/"><link rel="dns-prefetch" href="https://web.archive.org/web/20221028221515/https://xui.ptlogin2.qq.com/"><link rel="dns-prefetch" href="https://web.archive.org/web/20221028221515/https://q1.qlogo.cn/"><link rel="dns-prefetch" href="https://web.archive.org/web/20221028221515/https://q2.qlogo.cn/"><link rel="dns-prefetch" href="https://web.archive.org/web/20221028221515/https://q3.qlogo.cn/"><link rel="dns-prefetch" href="https://web.archive.org/web/20221028221515/https://q4.qlogo.cn/"><link rel="dns-prefetch" href="https://web.archive.org/web/20221028221515/https://q.qlogo.cn/"><link rel="dns-prefetch" href="https://web.archive.org/web/20221028221515/https://img01.sogoucdn.com/"><link rel="dns-prefetch" href="https://web.archive.org/web/20221028221515/https://img02.sogoucdn.com/"><link rel="dns-prefetch" href="https://web.archive.org/web/20221028221515/https://img03.sogoucdn.com/"><link rel="dns-prefetch" href="https://web.archive.org/web/20221028221515/https://img04.sogoucdn.com/"><link rel="Shortcut Icon" href="https://web.archive.org/web/20221028221515im_/https://www.sogou.com/images/logo/new/favicon.ico?v=4"><link rel="Bookmark" href="https://www.sogou.com/images/logo/new/favicon.ico?v=4"><link href="./d18154930745377030.缺氧诱导因子 - 搜狗科学百科_files/base_b849887.css" rel="stylesheet"><link href="./d18154930745377030.缺氧诱导因子 - 搜狗科学百科_files/detail_378aed5.css" rel="stylesheet"><link href="./d18154930745377030.缺氧诱导因子 - 搜狗科学百科_files/inviteAudit_7894507.css" rel="stylesheet"><link rel="stylesheet" href="./d18154930745377030.缺氧诱导因子 - 搜狗科学百科_files/highlight.min.css"><title>缺氧诱导因子 - 搜狗科学百科</title><style>.onekey-close {
	position: absolute;
	top: 16px;
	right: 16px;
	width: 24px;
	height: 24px;
	background: url(//web.archive.org/web/20221028205211/https://hhy.sogoucdn.com/js/common/hhy/sprite_wap_baike_37443f3.png) no-repeat;
	text-indent: -999em;
	background-size: 84px;
	background-position: -63px 0;
}

.onekey-login {
	position: absolute;
	top: 16.4%;
	left: 0;
	right: 0;
	width: 100%;
}

/* .onekey-login-img {
    width: 75px;
    height: 75px;
    background: url("https://web.archive.org/web/20221028221515/https://baike.sogou.com/kexue/images/sprite_wap_baike.png") no-repeat;
    background-size: 100px 91px;
    background-position: 0 0;
    background-repeat: no-repeat;
    margin: 0 auto;
} */

.onekey-login-title {
	text-align: center;
	padding-bottom: 3px;
	font-size: 21px;
	font-weight: bold;
	line-height: 30px;
	color: #000;
}

.onekey-login-txt {
	text-align: center;
	font-family: PingFangSC;
	font-size: 14px;
	line-height: 20px;
	color: #8f8f8f;
}

.onekey-login-qq,
.onekey-login-wx,
.onekey-login-phone {
	display: block;
	width: 245px;
	height: 54px;
	border-radius: 45px;
	text-align: center;

	margin: 0 auto;
	font-size: 17px;
	line-height: 24px;
	color: #000;
	/* padding: 16px 77px; */
	border-radius: 12px;
	border: solid 1px #e0e0e0;
}
.onekey-qq-content,
.onekey-vx-content,
.onekey-phone-content {
	display: inline-block;
	margin-top: 16px;
}
.onekey-qq-content {
	padding: 0 5px;
}

.onekey-login-qq {
	margin-top: 48px;
	margin-bottom: 24px;
}

.onekey-login-qq:before {
	display: inline-block;
	content: "";
	width: 20px;
	height: 20px;
	background: url(//web.archive.org/web/20221028205211/https://hhy.sogoucdn.com/js/common/hhy/sprite_wap_baike_37443f3.png) no-repeat;
	background-size: 80px;
	background-position: -20px 0;
	vertical-align: top;
	margin: 17px 8px 0 0;
}

.onekey-login-wx {
	margin-bottom: 24px;
}

.onekey-login-wx:before {
	display: inline-block;
	content: "";
	width: 21px;
	height: 21px;
	background: url(//web.archive.org/web/20221028205211/https://hhy.sogoucdn.com/js/common/hhy/sprite_wap_baike_37443f3.png) no-repeat;
	background-size: 84px;
	background-position: 0 0;
	vertical-align: top;
	margin: 17px 10px 0 0;
}

.onekey-login-phone {
}

.onekey-login-phone:before {
	display: inline-block;
	content: "";
	width: 21px;
	height: 21px;
	background: url(//web.archive.org/web/20221028205211/https://hhy.sogoucdn.com/js/common/hhy/sprite_wap_baike_37443f3.png) no-repeat;
	background-size: 84px;
	background-position: -42px 0;
	vertical-align: top;
	margin: 17px 10px 0 0;
}

.onekey-fixed {
	z-index: 100;
	position: fixed;
	top: 0;
	bottom: 0;
	left: 0;
	right: 0;
	background: #fff;
	width: 100%;
	height: 100%;
}

.onekey-fixed.forbid {
	z-index: 100;
	position: fixed;
	top: auto;
	bottom: 68px;
	left: 9%;
	right: 0;
	background: rgba(0, 0, 0, 0.7);
	width: 82%;
	height: 43px;
	border-radius: 25px;
	color: #ffffff;
}
.onekey-login-title.forbid {
	text-align: center;
	padding-bottom: 3px;
	font-size: 14px;
	font-weight: normal;
	line-height: 30px;
	color: white;
}
</style><style>#login_mask {
  background: #000;
  opacity: 0.5;
  filter: alpha(opacity=50);
  position: fixed;
  /*fixed好像在哪个IE上有BUG，先用用*/
  left: 0;
  top: 0;
  z-index: 999;
  height: 100%;
}

#login_iframe_container {
  position: fixed;
  width: 550px;
  height: 360px;
  z-index: 1020;
  background-color: #ffffff;
}

@media screen and (max-width: 828px) {
  #login_iframe_container {
    top: 50% !important;
    left: 50% !important;
    transform: translate(-50%, -50%);
  }
}

#login_iframe_container.new-login {
  width: 550px;
  height: 360px;
  background-image: url(//web.archive.org/web/20221028205211/https://hhy.sogoucdn.com/js/common/hhy/background_2a4a8a6.png);
}

#login_iframe_container.new-login.no-bg {
  background: #fff;
}

#login_iframe_container.new-login .login-title {
  width: 100%;
  height: 42px;
  line-height: 42px;
  text-align: center;
  font-size: 30px;
  letter-spacing: 0.19px;
  color: #ffffff;
  margin-top: 62px;
}
#login_iframe_container.new-login .forbid-title {
  width: 100%;
  height: 42px;
  line-height: 42px;
  text-align: center;
  font-size: 24px;
  letter-spacing: 0.19px;
  color: #333333;
  margin-top: 150px;
}

#login_iframe_container.new-login.no-bg .login-title {
  color: #333333;
}

#login_iframe_container.new-login .login-subtitle {
  width: 100%;
  height: 18px;
  line-height: 18px;
  font-size: 13px;
  letter-spacing: 0.08px;
  color: #ffffff;
  text-align: center;
  margin-top: 9px;
  margin-bottom: 43px;
}

#login_iframe_container.new-login.no-bg .login-subtitle {
  color: #999999;
}

#login_iframe_container.new-login .login-subtitle::before {
  content: '';
  display: inline-block;
  width: 10px;
  height: 1px;
  background-color: #ffffff;
  position: relative;
  top: -4px;
  left: -5px;
}

#login_iframe_container.new-login .login-subtitle::after {
  content: '';
  display: inline-block;
  width: 10px;
  height: 1px;
  background-color: #ffffff;
  position: relative;
  top: -4px;
  left: 5px;
}

#login_iframe_container.new-login.no-bg .login-subtitle::before {
  background-color: #999999;
}

#login_iframe_container.new-login.no-bg .login-subtitle::after {
  background-color: #999999;
}

#login_iframe_container.new-login .close-btn {
  position: absolute;
  top: 20px;
  right: 20px;
  width: 12px;
  height: 12px;
  background: url(//web.archive.org/web/20221028205211/https://hhy.sogoucdn.com/js/common/hhy/login-sprites_e3853e5.png) -59px -10px;
  background-size: 81px 91px;
  cursor: pointer;
}

#login_iframe_container.new-login .login-btn {
  width: 220px;
  height: 47px;
  border-radius: 24px;
  border: solid 1px #dddddd;
  background-color: #ffffff;
  margin: 0 auto;
  margin-top: 28px;
  position: relative;
  display: block;
}

#login_iframe_container.new-login .login-btn .login-icon {
  position: absolute;
}

#login_iframe_container.new-login .login-btn .login-text {
  width: 61px;
  height: 47px;
  line-height: 47px;
  vertical-align: middle;
  font-size: 15px;
  letter-spacing: 0.1px;
  color: #666666;
  position: absolute;
  right: 62px;
}

#login_iframe_container.new-login .login-btn.qq-btn .login-icon {
  width: 22px;
  height: 27px;
  top: 10px;
  left: 67px;
  background: url(//web.archive.org/web/20221028205211/https://hhy.sogoucdn.com/js/common/hhy/login-sprites_e3853e5.png) -10px -54px;
  background-size: 81px 91px;
}

#login_iframe_container.new-login .login-btn.qq-btn .login-text {
  right: 59px;
}

#login_iframe_container.new-login .login-btn.wechat-btn .login-icon {
  width: 29px;
  height: 24px;
  top: 12px;
  left: 62px;
  background: url(//web.archive.org/web/20221028205211/https://hhy.sogoucdn.com/js/common/hhy/login-sprites_e3853e5.png) -10px -10px;
  background-size: 81px 91px;
}</style><style>/* -- container -- */
.rodal,
.rodal-mask {
    top: 0;
    left: 0;
    width: 100%;
    height: 100%;
    z-index: 100;
}

.rodal {
    position: fixed;
}

/* -- mask -- */
.rodal-mask {
    position: fixed;
    background: rgba(0, 0, 0, .5);
}

/* -- dialog -- */
.rodal-dialog {
    position: absolute;
    z-index: 101;
    background: #fff;
    border-radius: 3px;
    box-shadow: 0 1px 3px rgba(0, 0, 0, .2);
}

.rodal-center {
    top: 50%;
    transform: translateY(-50%);
    left: 0;
    right: 0;
    margin: 0 auto;
}

.rodal-bottom {
    left: 0;
    right: 0;
    bottom: 0;
    margin: auto;
}

.rodal-top {
    left: 0;
    right: 0;
    top: 0;
    margin: auto;
}

.rodal-left {
    top: 0;
    left: 0;
    bottom: 0;
    margin: auto;
}

.rodal-right {
    top: 0;
    right: 0;
    bottom: 0;
    margin: auto;
}

/* -- close button -- */
.rodal-close {
    position: absolute;
    cursor: pointer;
    top: 16px;
    right: 16px;
    width: 16px;
    height: 16px;
}

.rodal-close:before,
.rodal-close:after {
    position: absolute;
    content: '';
    height: 2px;
    width: 100%;
    top: 50%;
    left: 0;
    margin-top: -1px;
    background: #999;
    border-radius: 100%;
    -webkit-transition: background .2s;
    transition: background .2s;
}

.rodal-close:before {
    -webkit-transform: rotate(45deg);
    transform: rotate(45deg);
}

.rodal-close:after {
    -webkit-transform: rotate(-45deg);
    transform: rotate(-45deg);
}

.rodal-close:hover:before,
.rodal-close:hover:after {
    background: #333;
}

/* -- fade -- */
/* @-webkit-keyframes rodal-fade-enter {
    from {
        opacity: 0;
    }
}

@keyframes rodal-fade-enter {
    from {
        opacity: 0;
    }
}

.rodal-fade-enter {
    -webkit-animation: rodal-fade-enter both ease-in;
    animation: rodal-fade-enter both ease-in;
} */

@-webkit-keyframes rodal-fade-leave {
    to {
        opacity: 0
    }
}

@keyframes rodal-fade-leave {
    to {
        opacity: 0
    }
}

.rodal-fade-leave {
    -webkit-animation: rodal-fade-leave both ease-out;
    animation: rodal-fade-leave both ease-out;
}

/* -- zoom -- */
@-webkit-keyframes rodal-zoom-enter {
    from {
        -webkit-transform: scale3d(.3, .3, .3);
        transform: scale3d(.3, .3, .3);
    }
}

@keyframes rodal-zoom-enter {
    from {
        -webkit-transform: scale3d(.3, .3, .3);
        transform: scale3d(.3, .3, .3);
    }
}

.rodal-zoom-enter {
    -webkit-animation: rodal-zoom-enter both cubic-bezier(0.4, 0, 0, 1.5);
    animation: rodal-zoom-enter both cubic-bezier(0.4, 0, 0, 1.5);
}

@-webkit-keyframes rodal-zoom-leave {
    to {
        -webkit-transform: scale3d(.3, .3, .3);
        transform: scale3d(.3, .3, .3);
    }
}

@keyframes rodal-zoom-leave {
    to {
        -webkit-transform: scale3d(.3, .3, .3);
        transform: scale3d(.3, .3, .3);
    }
}

.rodal-zoom-leave {
    -webkit-animation: rodal-zoom-leave both;
    animation: rodal-zoom-leave both;
}

/* -- slideDown -- */
@-webkit-keyframes rodal-slideDown-enter {
    from {
        -webkit-transform: translate3d(0, -100px, 0);
        transform: translate3d(0, -100px, 0);
    }
}

@keyframes rodal-slideDown-enter {
    from {
        -webkit-transform: translate3d(0, -100px, 0);
        transform: translate3d(0, -100px, 0);
    }
}

.rodal-slideDown-enter {
    -webkit-animation: rodal-slideDown-enter both cubic-bezier(0.4, 0, 0, 1.5);
    animation: rodal-slideDown-enter both cubic-bezier(0.4, 0, 0, 1.5);
}

@-webkit-keyframes rodal-slideDown-leave {
    to {
        -webkit-transform: translate3d(0, -100px, 0);
        transform: translate3d(0, -100px, 0);
    }
}

@keyframes rodal-slideDown-leave {
    to {
        -webkit-transform: translate3d(0, -100px, 0);
        transform: translate3d(0, -100px, 0);
    }
}

.rodal-slideDown-leave {
    -webkit-animation: rodal-slideDown-leave both;
    animation: rodal-slideDown-leave both;
}

/* -- slideLeft -- */
@-webkit-keyframes rodal-slideLeft-enter {
    from {
        -webkit-transform: translate3d(-150px, 0, 0);
        transform: translate3d(-150px, 0, 0);
    }
}

@keyframes rodal-slideLeft-enter {
    from {
        -webkit-transform: translate3d(-150px, 0, 0);
        transform: translate3d(-150px, 0, 0);
    }
}

.rodal-slideLeft-enter {
    -webkit-animation: rodal-slideLeft-enter both cubic-bezier(0.4, 0, 0, 1.5);
    animation: rodal-slideLeft-enter both cubic-bezier(0.4, 0, 0, 1.5);
}

@-webkit-keyframes rodal-slideLeft-leave {
    to {
        -webkit-transform: translate3d(-150px, 0, 0);
        transform: translate3d(-150px, 0, 0);
    }
}

@keyframes rodal-slideLeft-leave {
    to {
        -webkit-transform: translate3d(-150px, 0, 0);
        transform: translate3d(-150px, 0, 0);
    }
}

.rodal-slideLeft-leave {
    -webkit-animation: rodal-slideLeft-leave both;
    animation: rodal-slideLeft-leave both;
}

/* -- slideRight -- */
@-webkit-keyframes rodal-slideRight-enter {
    from {
        -webkit-transform: translate3d(150px, 0, 0);
        transform: translate3d(150px, 0, 0);
    }
}

@keyframes rodal-slideRight-enter {
    from {
        -webkit-transform: translate3d(150px, 0, 0);
        transform: translate3d(150px, 0, 0);
    }
}

.rodal-slideRight-enter {
    -webkit-animation: rodal-slideRight-enter both cubic-bezier(0.4, 0, 0, 1.5);
    animation: rodal-slideRight-enter both cubic-bezier(0.4, 0, 0, 1.5);
}

@-webkit-keyframes rodal-slideRight-leave {
    to {
        -webkit-transform: translate3d(150px, 0, 0);
        transform: translate3d(150px, 0, 0);
    }
}

@keyframes rodal-slideRight-leave {
    to {
        -webkit-transform: translate3d(150px, 0, 0);
        transform: translate3d(150px, 0, 0);
    }
}

.rodal-slideRight-leave {
    -webkit-animation: rodal-slideRight-leave both;
    animation: rodal-slideRight-leave both;
}

/* -- slideUp -- */
@-webkit-keyframes rodal-slideUp-enter {
    from {
        -webkit-transform: translate3d(0, 100px, 0);
        transform: translate3d(0, 100px, 0);
    }
}

@keyframes rodal-slideUp-enter {
    from {
        -webkit-transform: translate3d(0, 100px, 0);
        transform: translate3d(0, 100px, 0);
    }
}

.rodal-slideUp-enter {
    -webkit-animation: rodal-slideUp-enter both cubic-bezier(0.23, 1, 0.32, 1);
    animation: rodal-slideUp-enter both cubic-bezier(0.23, 1, 0.32, 1);
}

@-webkit-keyframes rodal-slideUp-leave {
    to {
        -webkit-transform: translate3d(0, 100px, 0);
        transform: translate3d(0, 100px, 0);
    }
}

@keyframes rodal-slideUp-leave {
    to {
        -webkit-transform: translate3d(0, 100px, 0);
        transform: translate3d(0, 100px, 0);
    }
}

.rodal-slideUp-leave {
    -webkit-animation: rodal-slideUp-leave both;
    animation: rodal-slideUp-leave both;
}

/* -- flip -- */
@-webkit-keyframes rodal-flip-enter {
    from {
        -webkit-transform: perspective(400px) rotate3d(1, 0, 0, 60deg);
        transform: perspective(400px) rotate3d(1, 0, 0, 60deg);
    }

    70% {
        -webkit-transform: perspective(400px) rotate3d(1, 0, 0, -15deg);
        transform: perspective(400px) rotate3d(1, 0, 0, -15deg);
    }

    to {
        -webkit-transform: perspective(400px);
        transform: perspective(400px);
    }
}

@keyframes rodal-flip-enter {
    from {
        -webkit-transform: perspective(400px) rotate3d(1, 0, 0, 60deg);
        transform: perspective(400px) rotate3d(1, 0, 0, 60deg);
    }

    70% {
        -webkit-transform: perspective(400px) rotate3d(1, 0, 0, -15deg);
        transform: perspective(400px) rotate3d(1, 0, 0, -15deg);
    }

    to {
        -webkit-transform: perspective(400px);
        transform: perspective(400px);
    }
}

.rodal-flip-enter {
    -webkit-animation: rodal-flip-enter both ease-in;
    animation: rodal-flip-enter both ease-in;
    -webkit-backface-visibility: visible !important;
    backface-visibility: visible !important;
}

@-webkit-keyframes rodal-flip-leave {
    from {
        -webkit-transform: perspective(400px);
        transform: perspective(400px);
    }

    30% {
        -webkit-transform: perspective(400px) rotate3d(1, 0, 0, -15deg);
        transform: perspective(400px) rotate3d(1, 0, 0, -15deg);
    }

    to {
        -webkit-transform: perspective(400px) rotate3d(1, 0, 0, 45deg);
        transform: perspective(400px) rotate3d(1, 0, 0, 45deg);
    }
}

@keyframes rodal-flip-leave {
    from {
        -webkit-transform: perspective(400px);
        transform: perspective(400px);
    }

    30% {
        -webkit-transform: perspective(400px) rotate3d(1, 0, 0, -15deg);
        transform: perspective(400px) rotate3d(1, 0, 0, -15deg);
    }

    to {
        -webkit-transform: perspective(400px) rotate3d(1, 0, 0, 45deg);
        transform: perspective(400px) rotate3d(1, 0, 0, 45deg);
    }
}

.rodal-flip-leave {
    -webkit-animation: rodal-flip-leave both;
    animation: rodal-flip-leave both;
    -webkit-backface-visibility: visible !important;
    backface-visibility: visible !important;
}

/* -- rotate -- */
@-webkit-keyframes rodal-rotate-enter {
    from {
        -webkit-transform: rotate3d(0, 0, 1, -180deg) scale3d(.3, .3, .3);
        transform: rotate3d(0, 0, 1, -180deg) scale3d(.3, .3, .3);
    }
}

@keyframes rodal-rotate-enter {
    from {
        -webkit-transform: rotate3d(0, 0, 1, -180deg) scale3d(.3, .3, .3);
        transform: rotate3d(0, 0, 1, -180deg) scale3d(.3, .3, .3);
    }
}

.rodal-rotate-enter {
    -webkit-animation: rodal-rotate-enter both;
    animation: rodal-rotate-enter both;
    -webkit-transform-origin: center;
    transform-origin: center;
}

@-webkit-keyframes rodal-rotate-leave {
    to {
        -webkit-transform: rotate3d(0, 0, 1, 180deg) scale3d(.3, .3, .3);
        transform: rotate3d(0, 0, 1, 180deg) scale3d(.3, .3, .3);
    }
}

@keyframes rodal-rotate-leave {
    to {
        -webkit-transform: rotate3d(0, 0, 1, 180deg) scale3d(.3, .3, .3);
        transform: rotate3d(0, 0, 1, 180deg) scale3d(.3, .3, .3);
    }
}

.rodal-rotate-leave {
    -webkit-animation: rodal-rotate-leave both;
    animation: rodal-rotate-leave both;
    -webkit-transform-origin: center;
    transform-origin: center;
}

/* -- door -- */
@-webkit-keyframes rodal-door-enter {
    from {
        -webkit-transform: scale3d(0, 1, 1);
        transform: scale3d(0, 1, 1);
    }
}

@keyframes rodal-door-enter {
    from {
        -webkit-transform: scale3d(0, 1, 1);
        transform: scale3d(0, 1, 1);
    }
}

.rodal-door-enter {
    -webkit-animation: rodal-door-enter both cubic-bezier(0.4, 0, 0, 1.5);
    animation: rodal-door-enter both cubic-bezier(0.4, 0, 0, 1.5);
}

@-webkit-keyframes rodal-door-leave {
    60% {
        -webkit-transform: scale3d(.01, 1, 1);
        transform: scale3d(.01, 1, 1);
    }

    to {
        -webkit-transform: scale3d(0, 1, .1);
        transform: scale3d(0, 1, .1);
    }
}

@keyframes rodal-door-leave {
    60% {
        -webkit-transform: scale3d(.01, 1, 1);
        transform: scale3d(.01, 1, 1);
    }

    to {
        -webkit-transform: scale3d(0, 1, .1);
        transform: scale3d(0, 1, .1);
    }
}

.rodal-door-leave {
    -webkit-animation: rodal-door-leave both;
    animation: rodal-door-leave both;
}</style><style>/* -- container -- */
.rodal,
.rodal-mask {
    top: 0;
    left: 0;
    width: 100%;
    height: 100%;
    z-index: 100;
}

.rodal {
    position: fixed;
}

/* -- mask -- */
.rodal-mask {
    position: fixed;
    background: rgba(0, 0, 0, .5);
}

/* -- dialog -- */
.rodal-dialog {
    position: absolute;
    z-index: 101;
    background: #fff;
    border-radius: 3px;
    box-shadow: 0 1px 3px rgba(0, 0, 0, .2);
}

.rodal-center {
    top: 50%;
    transform: translateY(-50%);
    left: 0;
    right: 0;
    margin: 0 auto;
}

.rodal-bottom {
    left: 0;
    right: 0;
    bottom: 0;
    margin: auto;
}

.rodal-top {
    left: 0;
    right: 0;
    top: 0;
    margin: auto;
}

.rodal-left {
    top: 0;
    left: 0;
    bottom: 0;
    margin: auto;
}

.rodal-right {
    top: 0;
    right: 0;
    bottom: 0;
    margin: auto;
}

/* -- close button -- */
.rodal-close {
    position: absolute;
    cursor: pointer;
    top: 16px;
    right: 16px;
    width: 16px;
    height: 16px;
}

.rodal-close:before,
.rodal-close:after {
    position: absolute;
    content: '';
    height: 2px;
    width: 100%;
    top: 50%;
    left: 0;
    margin-top: -1px;
    background: #999;
    border-radius: 100%;
    -webkit-transition: background .2s;
    transition: background .2s;
}

.rodal-close:before {
    -webkit-transform: rotate(45deg);
    transform: rotate(45deg);
}

.rodal-close:after {
    -webkit-transform: rotate(-45deg);
    transform: rotate(-45deg);
}

.rodal-close:hover:before,
.rodal-close:hover:after {
    background: #333;
}

/* -- fade -- */
/* @-webkit-keyframes rodal-fade-enter {
    from {
        opacity: 0;
    }
}

@keyframes rodal-fade-enter {
    from {
        opacity: 0;
    }
}

.rodal-fade-enter {
    -webkit-animation: rodal-fade-enter both ease-in;
    animation: rodal-fade-enter both ease-in;
} */

@-webkit-keyframes rodal-fade-leave {
    to {
        opacity: 0
    }
}

@keyframes rodal-fade-leave {
    to {
        opacity: 0
    }
}

.rodal-fade-leave {
    -webkit-animation: rodal-fade-leave both ease-out;
    animation: rodal-fade-leave both ease-out;
}

/* -- zoom -- */
@-webkit-keyframes rodal-zoom-enter {
    from {
        -webkit-transform: scale3d(.3, .3, .3);
        transform: scale3d(.3, .3, .3);
    }
}

@keyframes rodal-zoom-enter {
    from {
        -webkit-transform: scale3d(.3, .3, .3);
        transform: scale3d(.3, .3, .3);
    }
}

.rodal-zoom-enter {
    -webkit-animation: rodal-zoom-enter both cubic-bezier(0.4, 0, 0, 1.5);
    animation: rodal-zoom-enter both cubic-bezier(0.4, 0, 0, 1.5);
}

@-webkit-keyframes rodal-zoom-leave {
    to {
        -webkit-transform: scale3d(.3, .3, .3);
        transform: scale3d(.3, .3, .3);
    }
}

@keyframes rodal-zoom-leave {
    to {
        -webkit-transform: scale3d(.3, .3, .3);
        transform: scale3d(.3, .3, .3);
    }
}

.rodal-zoom-leave {
    -webkit-animation: rodal-zoom-leave both;
    animation: rodal-zoom-leave both;
}

/* -- slideDown -- */
@-webkit-keyframes rodal-slideDown-enter {
    from {
        -webkit-transform: translate3d(0, -100px, 0);
        transform: translate3d(0, -100px, 0);
    }
}

@keyframes rodal-slideDown-enter {
    from {
        -webkit-transform: translate3d(0, -100px, 0);
        transform: translate3d(0, -100px, 0);
    }
}

.rodal-slideDown-enter {
    -webkit-animation: rodal-slideDown-enter both cubic-bezier(0.4, 0, 0, 1.5);
    animation: rodal-slideDown-enter both cubic-bezier(0.4, 0, 0, 1.5);
}

@-webkit-keyframes rodal-slideDown-leave {
    to {
        -webkit-transform: translate3d(0, -100px, 0);
        transform: translate3d(0, -100px, 0);
    }
}

@keyframes rodal-slideDown-leave {
    to {
        -webkit-transform: translate3d(0, -100px, 0);
        transform: translate3d(0, -100px, 0);
    }
}

.rodal-slideDown-leave {
    -webkit-animation: rodal-slideDown-leave both;
    animation: rodal-slideDown-leave both;
}

/* -- slideLeft -- */
@-webkit-keyframes rodal-slideLeft-enter {
    from {
        -webkit-transform: translate3d(-150px, 0, 0);
        transform: translate3d(-150px, 0, 0);
    }
}

@keyframes rodal-slideLeft-enter {
    from {
        -webkit-transform: translate3d(-150px, 0, 0);
        transform: translate3d(-150px, 0, 0);
    }
}

.rodal-slideLeft-enter {
    -webkit-animation: rodal-slideLeft-enter both cubic-bezier(0.4, 0, 0, 1.5);
    animation: rodal-slideLeft-enter both cubic-bezier(0.4, 0, 0, 1.5);
}

@-webkit-keyframes rodal-slideLeft-leave {
    to {
        -webkit-transform: translate3d(-150px, 0, 0);
        transform: translate3d(-150px, 0, 0);
    }
}

@keyframes rodal-slideLeft-leave {
    to {
        -webkit-transform: translate3d(-150px, 0, 0);
        transform: translate3d(-150px, 0, 0);
    }
}

.rodal-slideLeft-leave {
    -webkit-animation: rodal-slideLeft-leave both;
    animation: rodal-slideLeft-leave both;
}

/* -- slideRight -- */
@-webkit-keyframes rodal-slideRight-enter {
    from {
        -webkit-transform: translate3d(150px, 0, 0);
        transform: translate3d(150px, 0, 0);
    }
}

@keyframes rodal-slideRight-enter {
    from {
        -webkit-transform: translate3d(150px, 0, 0);
        transform: translate3d(150px, 0, 0);
    }
}

.rodal-slideRight-enter {
    -webkit-animation: rodal-slideRight-enter both cubic-bezier(0.4, 0, 0, 1.5);
    animation: rodal-slideRight-enter both cubic-bezier(0.4, 0, 0, 1.5);
}

@-webkit-keyframes rodal-slideRight-leave {
    to {
        -webkit-transform: translate3d(150px, 0, 0);
        transform: translate3d(150px, 0, 0);
    }
}

@keyframes rodal-slideRight-leave {
    to {
        -webkit-transform: translate3d(150px, 0, 0);
        transform: translate3d(150px, 0, 0);
    }
}

.rodal-slideRight-leave {
    -webkit-animation: rodal-slideRight-leave both;
    animation: rodal-slideRight-leave both;
}

/* -- slideUp -- */
@-webkit-keyframes rodal-slideUp-enter {
    from {
        -webkit-transform: translate3d(0, 100px, 0);
        transform: translate3d(0, 100px, 0);
    }
}

@keyframes rodal-slideUp-enter {
    from {
        -webkit-transform: translate3d(0, 100px, 0);
        transform: translate3d(0, 100px, 0);
    }
}

.rodal-slideUp-enter {
    -webkit-animation: rodal-slideUp-enter both cubic-bezier(0.23, 1, 0.32, 1);
    animation: rodal-slideUp-enter both cubic-bezier(0.23, 1, 0.32, 1);
}

@-webkit-keyframes rodal-slideUp-leave {
    to {
        -webkit-transform: translate3d(0, 100px, 0);
        transform: translate3d(0, 100px, 0);
    }
}

@keyframes rodal-slideUp-leave {
    to {
        -webkit-transform: translate3d(0, 100px, 0);
        transform: translate3d(0, 100px, 0);
    }
}

.rodal-slideUp-leave {
    -webkit-animation: rodal-slideUp-leave both;
    animation: rodal-slideUp-leave both;
}

/* -- flip -- */
@-webkit-keyframes rodal-flip-enter {
    from {
        -webkit-transform: perspective(400px) rotate3d(1, 0, 0, 60deg);
        transform: perspective(400px) rotate3d(1, 0, 0, 60deg);
    }

    70% {
        -webkit-transform: perspective(400px) rotate3d(1, 0, 0, -15deg);
        transform: perspective(400px) rotate3d(1, 0, 0, -15deg);
    }

    to {
        -webkit-transform: perspective(400px);
        transform: perspective(400px);
    }
}

@keyframes rodal-flip-enter {
    from {
        -webkit-transform: perspective(400px) rotate3d(1, 0, 0, 60deg);
        transform: perspective(400px) rotate3d(1, 0, 0, 60deg);
    }

    70% {
        -webkit-transform: perspective(400px) rotate3d(1, 0, 0, -15deg);
        transform: perspective(400px) rotate3d(1, 0, 0, -15deg);
    }

    to {
        -webkit-transform: perspective(400px);
        transform: perspective(400px);
    }
}

.rodal-flip-enter {
    -webkit-animation: rodal-flip-enter both ease-in;
    animation: rodal-flip-enter both ease-in;
    -webkit-backface-visibility: visible !important;
    backface-visibility: visible !important;
}

@-webkit-keyframes rodal-flip-leave {
    from {
        -webkit-transform: perspective(400px);
        transform: perspective(400px);
    }

    30% {
        -webkit-transform: perspective(400px) rotate3d(1, 0, 0, -15deg);
        transform: perspective(400px) rotate3d(1, 0, 0, -15deg);
    }

    to {
        -webkit-transform: perspective(400px) rotate3d(1, 0, 0, 45deg);
        transform: perspective(400px) rotate3d(1, 0, 0, 45deg);
    }
}

@keyframes rodal-flip-leave {
    from {
        -webkit-transform: perspective(400px);
        transform: perspective(400px);
    }

    30% {
        -webkit-transform: perspective(400px) rotate3d(1, 0, 0, -15deg);
        transform: perspective(400px) rotate3d(1, 0, 0, -15deg);
    }

    to {
        -webkit-transform: perspective(400px) rotate3d(1, 0, 0, 45deg);
        transform: perspective(400px) rotate3d(1, 0, 0, 45deg);
    }
}

.rodal-flip-leave {
    -webkit-animation: rodal-flip-leave both;
    animation: rodal-flip-leave both;
    -webkit-backface-visibility: visible !important;
    backface-visibility: visible !important;
}

/* -- rotate -- */
@-webkit-keyframes rodal-rotate-enter {
    from {
        -webkit-transform: rotate3d(0, 0, 1, -180deg) scale3d(.3, .3, .3);
        transform: rotate3d(0, 0, 1, -180deg) scale3d(.3, .3, .3);
    }
}

@keyframes rodal-rotate-enter {
    from {
        -webkit-transform: rotate3d(0, 0, 1, -180deg) scale3d(.3, .3, .3);
        transform: rotate3d(0, 0, 1, -180deg) scale3d(.3, .3, .3);
    }
}

.rodal-rotate-enter {
    -webkit-animation: rodal-rotate-enter both;
    animation: rodal-rotate-enter both;
    -webkit-transform-origin: center;
    transform-origin: center;
}

@-webkit-keyframes rodal-rotate-leave {
    to {
        -webkit-transform: rotate3d(0, 0, 1, 180deg) scale3d(.3, .3, .3);
        transform: rotate3d(0, 0, 1, 180deg) scale3d(.3, .3, .3);
    }
}

@keyframes rodal-rotate-leave {
    to {
        -webkit-transform: rotate3d(0, 0, 1, 180deg) scale3d(.3, .3, .3);
        transform: rotate3d(0, 0, 1, 180deg) scale3d(.3, .3, .3);
    }
}

.rodal-rotate-leave {
    -webkit-animation: rodal-rotate-leave both;
    animation: rodal-rotate-leave both;
    -webkit-transform-origin: center;
    transform-origin: center;
}

/* -- door -- */
@-webkit-keyframes rodal-door-enter {
    from {
        -webkit-transform: scale3d(0, 1, 1);
        transform: scale3d(0, 1, 1);
    }
}

@keyframes rodal-door-enter {
    from {
        -webkit-transform: scale3d(0, 1, 1);
        transform: scale3d(0, 1, 1);
    }
}

.rodal-door-enter {
    -webkit-animation: rodal-door-enter both cubic-bezier(0.4, 0, 0, 1.5);
    animation: rodal-door-enter both cubic-bezier(0.4, 0, 0, 1.5);
}

@-webkit-keyframes rodal-door-leave {
    60% {
        -webkit-transform: scale3d(.01, 1, 1);
        transform: scale3d(.01, 1, 1);
    }

    to {
        -webkit-transform: scale3d(0, 1, .1);
        transform: scale3d(0, 1, .1);
    }
}

@keyframes rodal-door-leave {
    60% {
        -webkit-transform: scale3d(.01, 1, 1);
        transform: scale3d(.01, 1, 1);
    }

    to {
        -webkit-transform: scale3d(0, 1, .1);
        transform: scale3d(0, 1, .1);
    }
}

.rodal-door-leave {
    -webkit-animation: rodal-door-leave both;
    animation: rodal-door-leave both;
}</style></head><body class=""><!-- BEGIN WAYBACK TOOLBAR INSERT -->
<style type="text/css">
body {
  margin-top:0 !important;
  padding-top:0 !important;
  /*min-width:800px !important;*/
}
</style>
<script>__wm.rw(0);</script>
<div id="wm-ipp-base" lang="en" style="display: block; direction: ltr;">
</div><div id="wm-ipp-print">The Wayback Machine - https://web.archive.org/web/20221028221515/https://baike.sogou.com/kexue/d18154930745377030.htm</div>
<script type="text/javascript">//<![CDATA[
__wm.bt(675,27,25,2,"web","https://baike.sogou.com/kexue/d18154930745377030.htm","20221028221515",1996,"/_static/",["/_static/css/banner-styles.css?v=S1zqJCYt","/_static/css/iconochive.css?v=qtvMKcIJ"], false);
  __wm.rw(1);
//]]></script>
<!-- END WAYBACK TOOLBAR INSERT --><script>window._gtag=window._gtag||{};window._gtag.shouldGrayed = false;if ('338158932f614bb3a9058c0a2d253c7c') window._gtag.traceId = '338158932f614bb3a9058c0a2d253c7c';if ({"illegality":true}) window.userInfo = {"illegality":true};</script><div class="topnavbox"><ul class="topnav"><li><a href="https://web.archive.org/web/20221028221515/https://www.sogou.com/web?query=">网页</a></li><li><a href="https://web.archive.org/web/20221028221515/https://weixin.sogou.com/weixin?p=75351201">微信</a></li><li><a href="https://web.archive.org/web/20221028221515/https://zhihu.sogou.com/zhihu?p=75351218">知乎</a></li><li><a href="https://web.archive.org/web/20221028221515/https://pic.sogou.com/pics?query=">图片</a></li><li><a href="https://web.archive.org/web/20221028221515/https://v.sogou.com/v?query=">视频</a></li><li><a href="https://web.archive.org/web/20221028221515/https://mingyi.sogou.com/">医疗</a></li><li class="cur"><strong>科学</strong></li><li><a href="https://web.archive.org/web/20221028221515/https://hanyu.sogou.com/">汉语</a></li><li><a href="https://web.archive.org/web/20221028221515/https://wenwen.sogou.com/">问问</a></li><li><a href="https://web.archive.org/web/20221028221515/https://www.sogou.com/docs/more.htm">更多<span class="topraquo">»</span></a></li></ul></div><div id="header"><div class="header-wrap"><a class="header-logo" href="https://web.archive.org/web/20221028221515/https://baike.sogou.com/kexue"></a><div class="header-search"><div class="querybox" id="suggBox"><form><input id="searchInput" class="query" type="text" placeholder="搜科学领域专业百科词条" name="query" autocomplete="off" value=""><a href="javascript:;" class="query-search"></a></form></div></div><div class="header-rgt"><span class="btn-header-rgt btn-edit" id="editLemma">创建</span><div class="header-user no-login"></div></div></div></div><div class="fixed-placeholder" style="visibility:none"></div><div id="container" class=""><div class="content lemma-level1"><div class="detail-title" id="abstract-title"><h1>缺氧诱导因子</h1><a href="https://web.archive.org/web/20221028221515/https://baike.sogou.com/kexue/d18154930745377030.htm#!" class="detail-edit">编辑</a></div><div class="section_content" data-id="20039536910282519"><div><p>缺氧诱导因子（Hypoxia Inducible Factor, HIF）是一种可以对细胞内氧气浓度变化做出响应的转录因子。在缺氧条件下，缺氧诱导因子发挥转录调节活性，控制一系列代谢相关基因的表达，以帮助细胞和机体系统性地适应缺氧环境。缺氧诱导因子在许多生理和病理过程中扮演了重要角色，因此，其发现者格雷格·西门扎（Gregg L. Semenza）与其他两位科学家分享了2019年诺贝尔生理与医学奖。<sup><a href="https://web.archive.org/web/20221028221515/https://baike.sogou.com/kexue/d18154930745377030.htm#quote_1" class="kx_ref">[1]</a></sup></p></div></div><div id="catalog"><h2 class="title2">目录<a href="javascript:" class="detail-edit">编辑</a></h2><div class="catalog_wrap" style=""><ul class="catalog_list col2"><li><span class="order">1</span><a href="javascript:" data-level="1" data-id="20039536927059713">组成</a></li><li><span class="order">2</span><a href="javascript:" data-level="1" data-id="20039536927059714">结构</a></li><li><span class="order">3</span><a href="javascript:" data-level="1" data-id="20039536927059715">缺氧调控的信号通路</a></li><li><span class="order">4</span><a href="javascript:" data-level="1" data-id="20039536927059716">缺氧诱导因子与海洋哺乳动物的缺氧适应</a></li><li><span class="order">5</span><a href="javascript:" data-level="1" data-id="20039536943836941">缺氧诱导因子与人类疾病</a></li><li class="secondary_catalog"><span>5.1 </span><a href="javascript:" data-id="20039536943836941">恶性肿瘤</a></li></ul><ul class="catalog_list col2"><li class="secondary_catalog"><span>5.2 </span><a href="javascript:" data-id="20039536943836941">缺血性中风</a></li><li class="secondary_catalog"><span>5.3 </span><a href="javascript:" data-id="20039536943836941">冠心病</a></li><li class="secondary_catalog"><span>5.4 </span><a href="javascript:" data-id="20039536943836941">其他疾病</a></li><li><span class="order">6</span><a href="javascript:" data-level="1" data-id="20039536943836942">缺氧诱导因子相关的药物研发</a></li><li><span class="order">7</span><a href="javascript:" data-level="1" data-id="references">参考文献</a></li></ul></div></div><div id="paragraphs"><div><div id="par_20039536927059713"><h2 class="title">1 组成<a href="javascript:" class="detail-edit">编辑</a></h2><div class="section_content"><p>缺氧诱导因子存在于绝大多数有氧呼吸的后生动物中。不同生物中的HIF大致都可以分为两个亚基：α亚基和β亚基。β亚基又称芳香烃受体核转运子（aryl hydrocarbon receptor nuclear translocator, ARNT），在细胞内稳定表达。α亚基在正常氧浓度下被降解，当细胞内氧气分压降低时，α亚基才能稳定存在，继而与β亚基结合后发挥转录因子活性。故而，HIF的活性主要受α亚基调控。<sup><a href="https://web.archive.org/web/20221028221515/https://baike.sogou.com/kexue/d18154930745377030.htm#quote_2" class="kx_ref">[2]</a></sup></p></div></div><div id="par_20039536927059714"><h2 class="title">2 结构<a href="javascript:" class="detail-edit">编辑</a></h2><div class="section_content"><p>在高等多细胞生物中，共有三种HIFα亚基，其中HIF-1α和HIF-2α与缺氧应激关系密切，被研究的也最多。<sup><a href="https://web.archive.org/web/20221028221515/https://baike.sogou.com/kexue/d18154930745377030.htm#quote_3" class="kx_ref">[3]</a></sup>HIF-3α的结构和功能则尚不完全明确。<sup><a href="https://web.archive.org/web/20221028221515/https://baike.sogou.com/kexue/d18154930745377030.htm#quote_3" class="kx_ref">[3]</a></sup>HIF-1α和HIF-2α与HIF-β（ARNT）类似，都属于碱性螺旋-环-螺旋蛋白（basic Helix-Loop-Helix, bHLH）家族中的PAS（Per-Arnt-Sim）亚科，且都包含以下几个结构域<sup><a href="https://web.archive.org/web/20221028221515/https://baike.sogou.com/kexue/d18154930745377030.htm#quote_2" class="kx_ref">[2]</a></sup><sup><a href="https://web.archive.org/web/20221028221515/https://baike.sogou.com/kexue/d18154930745377030.htm#quote_3" class="kx_ref">[3]</a></sup>：<br></p><ol>
 <li><p>bHLH结构域：负责与DNA结合</p></li>
 <li><p>PAS结构域：负责形成二聚体</p></li>
 <li><p>C-末端激活结构域（C-Terminal Activation Domain, CTAD）：负责招募转录调节因子</p></li>
 <li><p>N-末端激活结构域（N-Terminal Activation Domain, NTAD）：可能与靶基因结合特异性有关</p></li>
</ol><p>除此之外，HIF的α亚基还包含一段“氧气依赖性降解结构域”（Oxygen-dependent Degradation Domain，ODD）。</p><p>2015年，Wu等利用X射线晶体衍射解析了第一组HIF-α-ARNT复合物的三维结构，并解析了HIF复合物与缺氧反应元件（Hypoxia Response Element, HRE）的DNA结合后的三维结构。<sup><a href="https://web.archive.org/web/20221028221515/https://baike.sogou.com/kexue/d18154930745377030.htm#quote_3" class="kx_ref">[3]</a></sup>通过该结构，研究人员发现HIF的α亚基和β亚基（ARNT）以一种非对称的方式形成二聚体，在与DNA结合时，HIF-α-ARNT复合物的构象发生变化，从而使bHLH结构域与HRE的DNA序列接触。<sup><a href="https://web.archive.org/web/20221028221515/https://baike.sogou.com/kexue/d18154930745377030.htm#quote_3" class="kx_ref">[3]</a></sup><sup><a href="https://web.archive.org/web/20221028221515/https://baike.sogou.com/kexue/d18154930745377030.htm#quote_4" class="kx_ref">[4]</a></sup>该结构还验证了几个癌症相关的HIF突变位点及其对HIF的影响。<sup><a href="https://web.archive.org/web/20221028221515/https://baike.sogou.com/kexue/d18154930745377030.htm#quote_3" class="kx_ref">[3]</a></sup><sup><a href="https://web.archive.org/web/20221028221515/https://baike.sogou.com/kexue/d18154930745377030.htm#quote_4" class="kx_ref">[4]</a></sup>通过对HIF-α-ARNT和小分子共结晶，他们还发现了几个潜在的药物分子结合位点，为调节HIF活性的药物开发提供了理论指导。<sup><a href="https://web.archive.org/web/20221028221515/https://baike.sogou.com/kexue/d18154930745377030.htm#quote_3" class="kx_ref">[3]</a></sup><sup><a href="https://web.archive.org/web/20221028221515/https://baike.sogou.com/kexue/d18154930745377030.htm#quote_4" class="kx_ref">[4]</a></sup></p><p></p><div class="text_img ed_imgfloat_right">
            <a class="ed_image_link lazyLoad" data-src="https://img02.sogoucdn.com/app/a/200698/895_481_20200108072031-981941481.png" data-bigsrc="https://img02.sogoucdn.com/app/a/200698/895_481_20200108072031-981941481.png" title="点击查看大图" href="javascript:" data-observer="true"></a>
            <div class="text_img_title">HIF-α-ARNT复合物未结合DNA (a) 以及结合DNA后 (b) 的结构示意图</div>   
        </div><p></p></div></div><div id="par_20039536927059715"><h2 class="title">3 缺氧调控的信号通路<a href="javascript:" class="detail-edit">编辑</a></h2><div class="section_content"><p>在正常氧分压下，脯氨酸羟化酶（prolyl hydroxylase domain-containing protein, PHD）可以催化HIF-1α的ODD结构域中的两个脯氨酸与氧气反应，发生羟基化。HIF-1α羟基化后，可以被另一种叫做VHL的蛋白（von Hippel-Lindau tumour suppressor protein）识别。VHL具有泛素化连接酶（ubiquitin ligase）活性，识别HIF-1α之后会为其打上泛素（ubiquitin）的“分子标签”。被打上泛素标签的蛋白质会被转运到蛋白酶体（proteasome）降解掉。因此，在正常氧分压下，HIF-1α迅速被降解，其半衰期很短，几乎不能被检测到。<sup><a href="https://web.archive.org/web/20221028221515/https://baike.sogou.com/kexue/d18154930745377030.htm#quote_5" class="kx_ref">[5]</a></sup><sup><a href="https://web.archive.org/web/20221028221515/https://baike.sogou.com/kexue/d18154930745377030.htm#quote_6" class="kx_ref">[6]</a></sup></p><p></p><div class="text_img ed_imgfloat_right">
            <a class="ed_image_link lazyLoad" data-src="https://img04.sogoucdn.com/app/a/200698/3508_2480_20200111031755-1724776499.png" data-bigsrc="https://img04.sogoucdn.com/app/a/200698/3508_2480_20200111031755-1724776499.png" title="点击查看大图" href="javascript:" data-observer="true"></a>
            <div class="text_img_title" style="text-align: center;"></div>   
        </div><p></p><p>由于氧气是脯氨酸羟化反应中的底物，在缺氧条件下，HIF-1α的脯氨酸不能被羟化，故而可以稳定存在。在细胞核输入蛋白（importin）的介导下，HIF-1α转运至细胞核中，并与那里的HIF-β结合，并招募其他转录调节因子如P300/CBP （CREB binding protein）形成活性复合体。该复合体继而与靶基因的缺氧反应元件（HRE）结合，从而激活一系列下游基因的转录。<sup><a href="https://web.archive.org/web/20221028221515/https://baike.sogou.com/kexue/d18154930745377030.htm#quote_6" class="kx_ref">[6]</a></sup></p><p>受HIF调控的下游基因包括促红细胞生成素（erythropoietin, EPO），血管内皮生长因子（vascular endothelial growth factor, VEGF），控制糖酵解的基因等。<sup><a href="https://web.archive.org/web/20221028221515/https://baike.sogou.com/kexue/d18154930745377030.htm#quote_7" class="kx_ref">[7]</a></sup>这些基因从不同角度提高机体对低氧环境的适应能力，例如EPO可以促进携氧的红细胞生成，VEGF可以促进血管生长，糖酵解可以解决缺氧环境下细胞的能量来源。可见，缺氧诱导因子处于缺氧调控信号通路的中心环节，起着牵一发而动全身的作用。<br></p></div></div><div id="par_20039536927059716"><h2 class="title">4 缺氧诱导因子与海洋哺乳动物的缺氧适应<a href="javascript:" class="detail-edit">编辑</a></h2><div class="section_content"><p>作为缺氧调控信号通路的中心环节，缺氧诱导因子在海洋哺乳动物的缺氧适应中有着重要作用。不同于鱼类，海洋哺乳动物（如海豹、海豚和鲸类）在水下活动时主要靠屏息潜水。这对海洋哺乳动物的缺氧耐受能力是一个很大的挑战。为了应对这一环境压力，海洋哺乳动物进化出了一系列机制。一方面，海洋哺乳动物的身体可以更多地储存氧气，另一方面，海洋哺乳动物可以更好地对缺氧/有氧的剧烈变化做出反应，调整代谢通路，从而避免缺氧带来的供能不足和有氧带来的氧化损伤。<sup><a href="https://web.archive.org/web/20221028221515/https://baike.sogou.com/kexue/d18154930745377030.htm#quote_8" class="kx_ref">[8]</a></sup></p><p>对HIF-1α的进化分析表明，在许多耐受缺氧环境的哺乳动物中，HIF-1α的氨基酸序列存在趋同进化的现象，这提示HIF-1α的进化参与了哺乳动物的缺氧适应。<sup><a href="https://web.archive.org/web/20221028221515/https://baike.sogou.com/kexue/d18154930745377030.htm#quote_9" class="kx_ref">[9]</a></sup>不同于人体，在海豹体内的一些组织中，HIF-1α可以在常氧下稳定存在。<sup><a href="https://web.archive.org/web/20221028221515/https://baike.sogou.com/kexue/d18154930745377030.htm#quote_10" class="kx_ref">[10]</a></sup>进一步研究表明，HIF-1α在海豹的肺部组织中表达最高，而在心肌组织中表达较低。<sup><a href="https://web.archive.org/web/20221028221515/https://baike.sogou.com/kexue/d18154930745377030.htm#quote_10" class="kx_ref">[10]</a></sup><sup><a href="https://web.archive.org/web/20221028221515/https://baike.sogou.com/kexue/d18154930745377030.htm#quote_11" class="kx_ref">[11]</a></sup>由于肺部面临着氧分压的剧烈变化，海豹肺部组织中的HIF-1α在常氧下稳定表达可以起到“预适应”的效果，从而避免了缺氧/有氧循环时的氧化损伤，而海豹肺部组织中被氧化蛋白含量较低也佐证了这一观点。<sup><a href="https://web.archive.org/web/20221028221515/https://baike.sogou.com/kexue/d18154930745377030.htm#quote_11" class="kx_ref">[11]</a></sup></p><p>对海豹HIF-1α的基因拷贝数和序列分析表明，海豹体内HIF-1α的稳定存在可能并非是由于HIF-1α基因本身发生突变导致的。<sup><a href="https://web.archive.org/web/20221028221515/https://baike.sogou.com/kexue/d18154930745377030.htm#quote_10" class="kx_ref">[10]</a></sup><sup><a href="https://web.archive.org/web/20221028221515/https://baike.sogou.com/kexue/d18154930745377030.htm#quote_11" class="kx_ref">[11]</a></sup>一种可能的机制是，海豹体内还原性的谷胱甘肽含量较高，从而阻止了HIF-1α在常氧下发生脯氨酸羟化反应。<sup><a href="https://web.archive.org/web/20221028221515/https://baike.sogou.com/kexue/d18154930745377030.htm#quote_12" class="kx_ref">[12]</a></sup><sup><a href="https://web.archive.org/web/20221028221515/https://baike.sogou.com/kexue/d18154930745377030.htm#quote_13" class="kx_ref">[13]</a></sup></p></div></div><div id="par_20039536943836941"><h2 class="title">5 缺氧诱导因子与人类疾病<a href="javascript:" class="detail-edit">编辑</a></h2><div class="section_content"><h3>5.1 <span>恶性肿瘤</span></h3><p>恶性肿瘤能摆脱机体控制无限增殖，在肿瘤细胞增殖过程中，往往处于缺氧微环境。近年来研究发现低氧可诱导癌细胞产生缺氧诱导因子。HIF在肿瘤适应缺氧环境、帮助肿瘤侵袭转移及对放化疗产生耐药性方面都起到重要作用。<sup><a href="https://web.archive.org/web/20221028221515/https://baike.sogou.com/kexue/d18154930745377030.htm#quote_14" class="kx_ref">[14]</a></sup></p><p>在HIF调控的下游基因里，有4类表达产物对肿瘤细胞适应缺氧微环境、侵袭、转移相关<sup><a href="https://web.archive.org/web/20221028221515/https://baike.sogou.com/kexue/d18154930745377030.htm#quote_14" class="kx_ref">[14]</a></sup>：</p><ol>
 <li><p>血管、淋巴管生成相关基因：主要包括血管内皮生长因子（VEGF）、血管生成素样蛋白（ANGPTL）、淋巴管内皮生长因子（VEGF-C）等。这些基因在HIF活化下表达，促进肿瘤附近血管和淋巴管生成，缓解肿瘤细胞缺氧程度，促进癌细胞沿血管或淋巴管转移。</p></li>
 <li><p>葡萄糖转运与糖酵解酶：包括乳酸脱氢酶A（LDHA）、丙酮酸脱氢酶激酶-1（PDK-1）等。这些酶表达上调促进肿瘤细胞进行无氧呼吸，缓解了缺氧微环境中的能量危机，帮助肿瘤细胞持续生长。</p></li>
 <li><p>肿瘤增殖和凋亡相关蛋白：研究表明癌细胞中HIF可以上调“含Caspase招募域的凋亡抑制蛋白”（apoptosis &nbsp;repressor &nbsp;with &nbsp;caspase &nbsp;recruitment &nbsp;domain，ARC）表达。ARC可抑制p53等多种凋亡相关基因的活性，干扰内外源死亡途径，使肿瘤细胞存活，增强肿瘤细胞对放化疗的抵抗力。</p></li>
 <li><p>促进上皮间质转化（epithelial &nbsp;mesenchymal &nbsp;transition，EMT）及细胞外基质降解相关因子：HIF诱导肿瘤细胞获得间叶源性表型特征，介导肿瘤细胞上皮间质转化。上皮间质转化是许多上皮系统肿瘤恶变的第一步。HIF还可促进基质金属蛋白酶（MMP）的表达，MMP协同降解细胞外基质（extracellular &nbsp;matrix，ECM），调控肿瘤细胞与ECM连接，在肿瘤侵袭转移中起到关键作用。</p></li>
</ol><h3>5.2 <span>缺血性中风</span></h3><p>缺血性中风，又称脑梗塞，是中风里最常见的一种类型。<sup><a href="https://web.archive.org/web/20221028221515/https://baike.sogou.com/kexue/d18154930745377030.htm#quote_15" class="kx_ref">[15]</a></sup>缺血性中风导致脑部缺血缺氧，由于成年人的神经细胞无法再生，故而往往产生永久性的后遗症。许多证据表明，在缺血性中风的过程中，缺氧诱导因子HIF-1α都会出现明显上调。<sup><a href="https://web.archive.org/web/20221028221515/https://baike.sogou.com/kexue/d18154930745377030.htm#quote_16" class="kx_ref">[16]</a></sup>大部分研究认为，HIF-1α的上调是一种保护机制。这种保护机制主要通过以下几个方面实现<sup><a href="https://web.archive.org/web/20221028221515/https://baike.sogou.com/kexue/d18154930745377030.htm#quote_16" class="kx_ref">[16]</a></sup><sup><a href="https://web.archive.org/web/20221028221515/https://baike.sogou.com/kexue/d18154930745377030.htm#quote_17" class="kx_ref">[17]</a></sup>：<br></p><ol>
 <li><p>HIF-1α可提高促红细胞生成素（EPO）的表达，EPO被认为有神经保护作用</p></li>
 <li><p>HIF-1α可提高血管生长因子（VEGF）的表达，VEGF可以促进新生血管生长，改善微循环，促进组织血液供应。</p></li>
 <li><p>HIF-1α可阻止细胞凋亡相关通路，促进细胞存活。</p></li>
</ol><p>然而，也有部分研究认为，HIF-1α的上调也可能在某些情况下产生不利影响。在一些中风损伤模型中，HIF-1α上调可导致p53表达上调，从而诱导细胞的延迟死亡。<sup><a href="https://web.archive.org/web/20221028221515/https://baike.sogou.com/kexue/d18154930745377030.htm#quote_16" class="kx_ref">[16]</a></sup>另外，HIF-1α在小胶质细胞中可促进炎症相关因子的表达，这也会加剧中风后的细胞损伤。<sup><a href="https://web.archive.org/web/20221028221515/https://baike.sogou.com/kexue/d18154930745377030.htm#quote_17" class="kx_ref">[17]</a></sup>总之，HIF-1α对神经系统的作用可能因中风缺血缺氧时间长短、以及不同类型的脑细胞而产生不同影响。<sup><a href="https://web.archive.org/web/20221028221515/https://baike.sogou.com/kexue/d18154930745377030.htm#quote_16" class="kx_ref">[16]</a></sup><sup><a href="https://web.archive.org/web/20221028221515/https://baike.sogou.com/kexue/d18154930745377030.htm#quote_17" class="kx_ref">[17]</a></sup></p><h3>5.3 <span>冠心病</span></h3><p>冠心病的本质是冠状动脉粥样硬化导致的心肌缺血。与缺血性中风类似，HIF被普遍认为对缺血性心脏病有保护性作用。<sup><a href="https://web.archive.org/web/20221028221515/https://baike.sogou.com/kexue/d18154930745377030.htm#quote_18" class="kx_ref">[18]</a></sup>HIF缺陷的实验小鼠对心肌梗塞的耐受能力更差。<sup><a href="https://web.archive.org/web/20221028221515/https://baike.sogou.com/kexue/d18154930745377030.htm#quote_18" class="kx_ref">[18]</a></sup>HIF对缺血心肌的保护机制与对脑卒中后神经组织的保护机制类似，都涉及促进新生血管生成、改变代谢通路以促进细胞存活等。另外，HIF还可以激活产生腺苷的基因，而腺苷被认为与心肌缺血的预适应有关。<sup><a href="https://web.archive.org/web/20221028221515/https://baike.sogou.com/kexue/d18154930745377030.htm#quote_18" class="kx_ref">[18]</a></sup></p><h3>5.4 <span>其他疾病</span></h3><p>缺氧诱导因子被认为在肺动脉高压的病理过程中有着重要作用。一系列主宰肺动脉平滑肌的缺氧改变的基因受HIF调控。在实验小鼠中，HIF-1α或HIF-2α基因缺失可以保护小鼠免于患上缺氧性肺动脉高压。这说明HIF对肺动脉高压的发生有促进作用。<sup><a href="https://web.archive.org/web/20221028221515/https://baike.sogou.com/kexue/d18154930745377030.htm#quote_18" class="kx_ref">[18]</a></sup></p><p>家族性红细胞增多症是具有遗传性的基因病，其特征表现为红细胞数增加。VHL、PHD2和HIF-2α的基因突变均可导致本病发生。<sup><a href="https://web.archive.org/web/20221028221515/https://baike.sogou.com/kexue/d18154930745377030.htm#quote_18" class="kx_ref">[18]</a></sup>这主要因为促红细胞生成素（EPO）是受HIF调控的，而任何基因突变导致的HIF通路上调都会增加EPO的表达，从而导致过多的红细胞生成。基于以上原理，现在已经开发出基因检测用以诊断这种罕见的遗传病。<sup><a href="https://web.archive.org/web/20221028221515/https://baike.sogou.com/kexue/d18154930745377030.htm#quote_19" class="kx_ref">[19]</a></sup></p></div></div><div id="par_20039536943836942"><h2 class="title">6 缺氧诱导因子相关的药物研发<a href="javascript:" class="detail-edit">编辑</a></h2><div class="section_content"><p>由于HIF对恶性肿瘤的促进作用，抑制HIF通路是一种抗癌的潜在途径。许多现有的化疗药物（如拓扑替康、依维莫司）可以间接地抑制HIF的活性，虽然这可能并非其主要的抗癌机理。直接通过抑制HIF通路来实现化疗作用的分子目前尚处于临床实验阶段，其机理包括抑制HIF的mRNA合成、抑制HIF的α亚基和β亚基结合、抑制HIF与DNA结合等。<sup><a href="https://web.archive.org/web/20221028221515/https://baike.sogou.com/kexue/d18154930745377030.htm#quote_20" class="kx_ref">[20]</a></sup><sup><a href="https://web.archive.org/web/20221028221515/https://baike.sogou.com/kexue/d18154930745377030.htm#quote_21" class="kx_ref">[21]</a></sup></p><p>在HIF-1α的降解过程的第一步，脯氨酸羟化酶（PHD）起到了关键的作用，故而，提高HIF通路可以通过抑制PHD得以实现。通过抑制PHD来提高HIF-1α活性，理论上可以对许多缺血性疾病起到治疗作用，这些疾病包括中风<sup><a href="https://web.archive.org/web/20221028221515/https://baike.sogou.com/kexue/d18154930745377030.htm#quote_22" class="kx_ref">[22]</a></sup>、冠心病<sup><a href="https://web.archive.org/web/20221028221515/https://baike.sogou.com/kexue/d18154930745377030.htm#quote_23" class="kx_ref">[23]</a></sup>、贫血等。目前，用于治疗慢性肾病导致的贫血的PHD抑制剂已进入临床III期研究。<sup><a href="https://web.archive.org/web/20221028221515/https://baike.sogou.com/kexue/d18154930745377030.htm#quote_24" class="kx_ref">[24]</a></sup></p><p>另外，有研究表明，在动物实验中，抑制PHD的活性可以大幅提高实验动物对无氧环境的耐受能力。<sup><a href="https://web.archive.org/web/20221028221515/https://baike.sogou.com/kexue/d18154930745377030.htm#quote_25" class="kx_ref">[25]</a></sup>相比正常小鼠，运动训练对PHD2缺陷的小鼠效果更佳。<sup><a href="https://web.archive.org/web/20221028221515/https://baike.sogou.com/kexue/d18154930745377030.htm#quote_26" class="kx_ref">[26]</a></sup>这意味着PHD抑制剂有潜力作为辅助药物，用以提高运动员（尤其是长跑、游泳、自由潜水等）在无氧条件下的表现。</p></div></div></div></div><div id="references"><h2 class="title" id="par_references">参考文献</h2><ul class="references"><li id="quote_1"><span class="references-num">[1]</span><p><a class="ref-back-btn">^</a><span data-url="https://web.archive.org/web/20221028221515/https://www.nobelprize.org/prizes/medicine/2019/summary/" class="blue">The Nobel Prize in Physiology or Medicine 2019..</span>Nobel Prize Official Website.</p></li><li id="quote_2"><span class="references-num">[2]</span><p><a class="ref-back-btn">^</a><span data-url="https://web.archive.org/web/20221028221515/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5470732/" class="blue">Hypoxia Inducible Factor (HIF) transcription factor family expansion, diversification, divergence and selection in eukaryotes..</span>NCBI.</p></li><li id="quote_3"><span class="references-num">[3]</span><p><a class="ref-back-btn">^</a><span data-url="https://web.archive.org/web/20221028221515/https://www.cell.com/molecular-cell/references/S1097-2765(08)00292-X" class="blue">Oxygen Sensing by Metazoans: The Central Role of the HIF Hydroxylase Pathway..</span>Molecular Cell.</p></li><li id="quote_4"><span class="references-num">[4]</span><p><a class="ref-back-btn">^</a><span data-url="https://web.archive.org/web/20221028221515/https://www.nature.com/articles/nature14641" class="blue">Hypoxia response becomes crystal clear..</span>Nature.</p></li><li id="quote_5"><span class="references-num">[5]</span><p><a class="ref-back-btn">^</a><span data-url="https://web.archive.org/web/20221028221515/https://www.nobelprize.org/prizes/medicine/2019/press-release/" class="blue">Press release: The Nobel Prize in Physiology or Medicine 2019..</span>Nobel prize official website.</p></li><li id="quote_6"><span class="references-num">[6]</span><p><a class="ref-back-btn">^</a><span data-url="https://web.archive.org/web/20221028221515/http://www.lifescience.net.cn/news/upload/2013140.pdf" class="blue">低氧诱导因子-1的调节。.</span>Chinese Bulletin of Life Sciences.</p></li><li id="quote_7"><span class="references-num">[7]</span><p><a class="ref-back-btn">^</a><span data-url="https://web.archive.org/web/20221028221515/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3388736/?report=classic" class="blue">Targeted genes and interacting proteins of hypoxia inducible factor-1..</span>NCBI.</p></li><li id="quote_8"><span class="references-num">[8]</span><p><a class="ref-back-btn">^</a><span data-url="https://web.archive.org/web/20221028221515/https://www.frontiersin.org/articles/10.3389/fphys.2019.01199/full" class="blue">Natural Tolerance to Ischemia and Hypoxemia in Diving Mammals: A Review..</span>Frontiers in Physiology.</p></li><li id="quote_9"><span class="references-num">[9]</span><p><a class="ref-back-btn">^</a><span data-url="https://web.archive.org/web/20221028221515/https://link.springer.com/article/10.1007/s00239-018-9870-8" class="blue">Evolutionary Genetics of Hypoxia and Cold Tolerance in Mammals..</span>Journal of Molecular Evolution.</p></li><li id="quote_10"><span class="references-num">[10]</span><p><a class="ref-back-btn">^</a><span data-url="https://web.archive.org/web/20221028221515/https://www.sciencedirect.com/science/article/abs/pii/S0891584905001346?via%3Dihub" class="blue">Hypoxia-inducible factor 1 proteomics and diving adaptations in ringed seal..</span>Free Radical Biology and Medicine.</p></li><li id="quote_11"><span class="references-num">[11]</span><p><a class="ref-back-btn">^</a><span data-url="https://web.archive.org/web/20221028221515/https://www.tandfonline.com/doi/abs/10.1080/10715760410001725526" class="blue">Hypoxia-Inducible Factor in Ringed Seal (Phoca hispida) Tissues..</span>Free Radical Research.</p></li><li id="quote_12"><span class="references-num">[12]</span><p><a class="ref-back-btn">^</a><span data-url="https://web.archive.org/web/20221028221515/https://www.sciencedirect.com/science/article/pii/S0022098107000950" class="blue">Glutathione protection against dive-associated ischemia/reperfusion in ringed seal tissues..</span>Journal of Experimental Marine Biology and Ecology.</p></li><li id="quote_13"><span class="references-num">[13]</span><p><a class="ref-back-btn">^</a><span data-url="https://web.archive.org/web/20221028221515/https://www.academia.edu/10363650/Ischemia_Reperfusion_in_Diving_Birds_and_Mammals_How_They_Avoid_Oxidative_Damage" class="blue">Ischemia/Reperfusion in Diving Birds and Mammals: How They Avoid Oxidative Damage..</span>Academia.edu.</p></li><li id="quote_14"><span class="references-num">[14]</span><p><a class="ref-back-btn">^</a><span data-url="https://web.archive.org/web/20221028221515/http://www.cnki.com.cn/Article/CJFDTotal-WYSB201302013.htm" class="blue">HIF-1表达在肿瘤生长及演进中的作用。.</span>国际病理科学与临床杂志.</p></li><li id="quote_15"><span class="references-num">[15]</span><p><a class="ref-back-btn">^</a><span data-url="https://web.archive.org/web/20221028221515/https://www.stroke.org/en/about-stroke/types-of-stroke" class="blue">Types of Stroke..</span>American Stroke Association.</p></li><li id="quote_16"><span class="references-num">[16]</span><p><a class="ref-back-btn">^</a><span data-url="https://web.archive.org/web/20221028221515/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2819104/" class="blue">Hypoxia Inducible Factor 1 as a Therapeutic Target in Ischemic Stroke..</span>NCBI.</p></li><li id="quote_17"><span class="references-num">[17]</span><p><a class="ref-back-btn">^</a><span data-url="https://web.archive.org/web/20221028221515/https://link.springer.com/article/10.1007/s10571-012-9803-9#Sec20" class="blue">Hypoxia Inducible Factor-1: Its Potential Role In Cerebral Ischemia..</span>Cellular and Molecular Neurobiology.</p></li><li id="quote_18"><span class="references-num">[18]</span><p><a class="ref-back-btn">^</a><span data-url="https://web.archive.org/web/20221028221515/https://www.cell.com/fulltext/S0092-8674(12)00087-6" class="blue">Hypoxia-Inducible Factors in Physiology and Medicine..</span>Cell.</p></li><li id="quote_19"><span class="references-num">[19]</span><p><a class="ref-back-btn">^</a><span data-url="https://web.archive.org/web/20221028221515/https://zhuanlan.zhihu.com/p/31380266" class="blue">红细胞增多症基因检测。.</span>知乎专栏.</p></li><li id="quote_20"><span class="references-num">[20]</span><p><a class="ref-back-btn">^</a><span data-url="https://web.archive.org/web/20221028221515/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5368132/" class="blue">Development of Inhibitors Targeting Hypoxia-Inducible Factor 1 and 2 for Cancer Therapy..</span>NCBI.</p></li><li id="quote_21"><span class="references-num">[21]</span><p><a class="ref-back-btn">^</a><span data-url="https://web.archive.org/web/20221028221515/https://link.springer.com/article/10.1007%2Fs11912-019-0752-z#Sec13" class="blue">HIF Inhibitors: Status of Current Clinical Development..</span>Current Oncology Reports.</p></li><li id="quote_22"><span class="references-num">[22]</span><p><a class="ref-back-btn">^</a><span data-url="https://web.archive.org/web/20221028221515/https://journals.sagepub.com/doi/full/10.1038/jcbfm.2012.28" class="blue">Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibition: Robust New Target or Another Big Bust for Stroke Therapeutics?.</span>Journal of Cerebral Blood Flow &amp;amp; Metabolism.</p></li><li id="quote_23"><span class="references-num">[23]</span><p><a class="ref-back-btn">^</a><span data-url="https://web.archive.org/web/20221028221515/https://journals.lww.com/cardiovascularpharm/Fulltext/2010/08000/Chronic_Inhibition_of_Hypoxia_inducible_Factor.5.aspx?casa_token=SFxiXNINKJgAAAAA:RWQbpvGfwbA9ruAu85Ip_Ia4xwex4bEpC-sPwDUkbXlwebPV813xbAuesSHTNEDwzMUD_QeTQiMYolUJ3bCDZ79o" class="blue">Chronic Inhibition of Hypoxia-inducible Factor Prolyl 4-hydroxylase Improves Ventricular Performance, Remodeling, and Vascularity After Myocardial Infarction in the Rat..</span>Journal of Cardiovascular Pharmacology.</p></li><li id="quote_24"><span class="references-num">[24]</span><p><a class="ref-back-btn">^</a><span data-url="https://web.archive.org/web/20221028221515/http://jpet.aspetjournals.org/content/363/3/336" class="blue">Discovery and Preclinical Characterization of GSK1278863 (Daprodustat), a Small Molecule Hypoxia Inducible Factor–Prolyl Hydroxylase Inhibitor for Anemia..</span>Journal of Pharmacology and Experimental Therapeutics.</p></li><li id="quote_25"><span class="references-num">[25]</span><p><a class="ref-back-btn">^</a><span data-url="https://web.archive.org/web/20221028221515/https://onlinelibrary.wiley.com/doi/full/10.1111/j.1748-1716.2007.01676.x?casa_token=gsCX3JljbJQAAAAA%3A9kkLuaCGsxVF0QIgh_rJyG2o8Py2O4GKiZxq_P_Wz0ciYuMAKTQbRmAc5slTg1kohE7viw850IOGN1o" class="blue">Prolyl hydroxylase inhibitor treatment confers whole‐animal hypoxia tolerance..</span>Acta Physiologica.</p></li><li id="quote_26"><span class="references-num">[26]</span><p><a class="ref-back-btn">^</a><span data-url="https://web.archive.org/web/20221028221515/https://onlinelibrary.wiley.com/doi/full/10.1111/apha.12751" class="blue">Activation of the hypoxia‐inducible factor pathway induced by prolyl hydroxylase domain 2 deficiency enhances the effect of running training in mice..</span>Acta Physiologica.</p></li></ul></div><div class="read-num">阅读 <!-- -->771</div></div><div class="right-side" id="rightSide"><div class="side" id="lemma-side"><div class="side-title">版本记录</div><ul class="side-lst"><li><p class="side-lst-txt">暂无</p></li></ul><div class="user-card userCard"></div></div><div class="side"><div class="side-event"></div></div></div></div><div class="footer-box"><div id="footer"><div class="footer-logo-wrap"><div class="footer-logo"></div><div class="footer-logo-text">知识·传播·科普</div></div><div class="footer-info">本网站内容采用<a target="_blank" href="https://web.archive.org/web/20221028221515/https://creativecommons.org/licenses/by-sa/3.0/deed.zh?tdsourcetag=s_pctim_aiomsg">CC-BY-SA 3.0</a>授权</div><div class="footer-btn-wrap"><a target="_blank" href="https://web.archive.org/web/20221028221515/https://baike.sogou.com/help/#user_protocol">用户协议</a><a target="_blank" href="https://web.archive.org/web/20221028221515/http://www.sogou.com/docs/terms.htm?v=1">免责声明</a><a target="_blank" href="https://web.archive.org/web/20221028221515/http://corp.sogou.com/private.html">隐私政策</a><a target="_blank" href="https://web.archive.org/web/20221028221515/https://baike.sogou.com/kexue/intro.htm">关于我们</a></div></div></div><script>window.lemmaInfo ={"lemmaId":"18154930745377030","versionId":"21206855502016008","title":"缺氧诱导因子","subtitle":"","abstracts":{"paragraphId":"20039536910282519","title":"简介","versionId":"20039536910282511","lemmaId":18154930745377030,"createType":0,"creator":{"uid":0,"name":null,"pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"createTime":0,"versionEditor":{"uid":77532282,"name":"胡天楠","pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"editTime":1579240494,"comment":null,"dependVersionId":0,"contentType":2,"content":"<p>缺氧诱导因子（Hypoxia Inducible Factor, HIF）是一种可以对细胞内氧气浓度变化做出响应的转录因子。在缺氧条件下，缺氧诱导因子发挥转录调节活性，控制一系列代谢相关基因的表达，以帮助细胞和机体系统性地适应缺氧环境。缺氧诱导因子在许多生理和病理过程中扮演了重要角色，因此，其发现者格雷格·西门扎（Gregg L. Semenza）与其他两位科学家分享了2019年诺贝尔生理与医学奖。<sup><a href=\"#quote_1\" class=\"kx_ref\">[1]</a></sup></p>","pics":null,"card":null,"references":[],"versionCount":0},"card":{"paragraphId":"20039536927059712","title":"基本信息","versionId":"20039536910282512","lemmaId":18154930745377030,"createType":0,"creator":{"uid":0,"name":null,"pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"createTime":0,"versionEditor":{"uid":77532282,"name":"胡天楠","pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"editTime":1579240494,"comment":null,"dependVersionId":0,"contentType":3,"content":"","pics":null,"card":{"cardItems":[{"key":"中文名","value":"缺氧诱导因子"},{"key":"英文名","value":"Hypoxia Inducible Factor"},{"key":"英文简称","value":"HIF"},{"key":"发现者","value":"Gregg L. Semenza"}]},"references":[],"versionCount":0},"categories":[{"id":143,"name":"生物化学","parents":[[{"id":4,"name":"生物学","parents":null}]]}],"creator":{"uid":77532282,"name":"胡天楠","pic":"https://web.archive.org/web/20221028221515/https://cache.soso.com/thirdwx_qlogo/mmopen/vi_32/Q0j4TwGTfTLlveSnKicrOD8ABGuGOT9lFkMd2wGmfl9v8GXuuCVCL5icB4IXMskU1xtQ1YDP2Yv5orkDQCZicYTIA/132","introduction":"","educations":[{"schoolName":"加州大学戴维斯分校","major":"","degree":"博士","universityId":114,"universityLogo":"","majorLevel1":null,"majorLevel2":null,"majorLevel3":null,"majorLevel1Id":0,"majorLevel2Id":0,"majorLevel3Id":0,"state":"毕业","lab":"","researchField":""}],"jobs":[{"company":"加州大学旧金山分校","title":"Assistant Specialist"}],"works":null,"educationBrief":"加州大学戴维斯分校","jobBrief":"Assistant Specialist","role":0,"roleName":null,"title":"加州大学戴维斯分校 · 博士","professionalTitle":"加州大学旧金山分校助理研究员","phoneNo":null,"editable":true,"partnerId":11,"partnerIdCreateTime":1594286496,"partnerIdPoped":true},"createTime":1578117181,"editor":{"uid":77532282,"name":"胡天楠","pic":"https://web.archive.org/web/20221028221515/https://cache.soso.com/thirdwx_qlogo/mmopen/vi_32/Q0j4TwGTfTLlveSnKicrOD8ABGuGOT9lFkMd2wGmfl9v8GXuuCVCL5icB4IXMskU1xtQ1YDP2Yv5orkDQCZicYTIA/132","introduction":"","educations":[{"schoolName":"加州大学戴维斯分校","major":"","degree":"博士","universityId":114,"universityLogo":"","majorLevel1":null,"majorLevel2":null,"majorLevel3":null,"majorLevel1Id":0,"majorLevel2Id":0,"majorLevel3Id":0,"state":"毕业","lab":"","researchField":""}],"jobs":[{"company":"加州大学旧金山分校","title":"Assistant Specialist"}],"works":null,"educationBrief":"加州大学戴维斯分校","jobBrief":"Assistant Specialist","role":0,"roleName":null,"title":"加州大学戴维斯分校 · 博士","professionalTitle":"加州大学旧金山分校助理研究员","phoneNo":null,"editable":true,"partnerId":11,"partnerIdCreateTime":1594286496,"partnerIdPoped":true},"editTime":1579936270,"state":1,"versionCount":2,"upNum":35,"downNum":0,"pics":[{"originalUrl":"https://web.archive.org/web/20221028221515/https://img02.sogoucdn.com/app/a/200698/895_481_20200108072031-981941481.png?w=895&h=481&titlename=HIF-%25CE%25B1-ARNT%25E5%25A4%258D%25E5%2590%2588%25E7%2589%25A9%25E6%259C%25AA%25E7%25BB%2593%25E5%2590%2588DNA%2520%2528a%2529%2520%25E4%25BB%25A5%25E5%258F%258A%25E7%25BB%2593%25E5%2590%2588DNA%25E5%2590%258E%2520%2528b%2529%2520%25E7%259A%2584%25E7%25BB%2593%25E6%259E%2584%25E7%25A4%25BA%25E6%2584%258F%25E5%259B%25BE","url":"https://web.archive.org/web/20221028221515/https://img02.sogoucdn.com/app/a/200698/895_481_20200108072031-981941481.png","rw":895,"rh":481,"title":"HIF-%CE%B1-ARNT%E5%A4%8D%E5%90%88%E7%89%A9%E6%9C%AA%E7%BB%93%E5%90%88DNA%20%28a%29%20%E4%BB%A5%E5%8F%8A%E7%BB%93%E5%90%88DNA%E5%90%8E%20%28b%29%20%E7%9A%84%E7%BB%93%E6%9E%84%E7%A4%BA%E6%84%8F%E5%9B%BE","alt":null,"width":0,"height":0},{"originalUrl":"https://web.archive.org/web/20221028221515/https://img04.sogoucdn.com/app/a/200698/3508_2480_20200111031755-1724776499.png?w=3508&h=2480","url":"https://web.archive.org/web/20221028221515/https://img04.sogoucdn.com/app/a/200698/3508_2480_20200111031755-1724776499.png","rw":3508,"rh":2480,"title":"","alt":null,"width":0,"height":0}],"catalogs":[{"level":1,"title":"组成","paragraphId":"20039536927059713","subCatalogs":null},{"level":1,"title":"结构","paragraphId":"20039536927059714","subCatalogs":null},{"level":1,"title":"缺氧调控的信号通路","paragraphId":"20039536927059715","subCatalogs":null},{"level":1,"title":"缺氧诱导因子与海洋哺乳动物的缺氧适应","paragraphId":"20039536927059716","subCatalogs":null},{"level":1,"title":"缺氧诱导因子与人类疾病","paragraphId":"20039536943836941","subCatalogs":[{"level":2,"title":"恶性肿瘤","paragraphId":"20039536943836941","subCatalogs":null},{"level":2,"title":"缺血性中风","paragraphId":"20039536943836941","subCatalogs":null},{"level":2,"title":"冠心病","paragraphId":"20039536943836941","subCatalogs":null},{"level":2,"title":"其他疾病","paragraphId":"20039536943836941","subCatalogs":null}]},{"level":1,"title":"缺氧诱导因子相关的药物研发","paragraphId":"20039536943836942","subCatalogs":null},{"level":1,"title":"参考文献","paragraphId":"-1","subCatalogs":null}],"paragraphs":[{"paragraphId":"20039536927059713","title":"组成","versionId":"21206855502016009","lemmaId":18154930745377030,"createType":0,"creator":{"uid":0,"name":null,"pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"createTime":0,"versionEditor":{"uid":77532282,"name":"胡天楠","pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"editTime":1579936270,"comment":null,"dependVersionId":0,"contentType":1,"content":"<p>缺氧诱导因子存在于绝大多数有氧呼吸的后生动物中。不同生物中的HIF大致都可以分为两个亚基：α亚基和β亚基。β亚基又称芳香烃受体核转运子（aryl hydrocarbon receptor nuclear translocator, ARNT），在细胞内稳定表达。α亚基在正常氧浓度下被降解，当细胞内氧气分压降低时，α亚基才能稳定存在，继而与β亚基结合后发挥转录因子活性。故而，HIF的活性主要受α亚基调控。<sup><a href=\"#quote_2\" class=\"kx_ref\">[2]</a></sup></p>","pics":null,"card":null,"references":[],"versionCount":0},{"paragraphId":"20039536927059714","title":"结构","versionId":"21206855502016010","lemmaId":18154930745377030,"createType":0,"creator":{"uid":0,"name":null,"pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"createTime":0,"versionEditor":{"uid":77532282,"name":"胡天楠","pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"editTime":1579936270,"comment":null,"dependVersionId":0,"contentType":1,"content":"<p>在高等多细胞生物中，共有三种HIFα亚基，其中HIF-1α和HIF-2α与缺氧应激关系密切，被研究的也最多。<sup><a href=\"#quote_3\" class=\"kx_ref\">[3]</a></sup>HIF-3α的结构和功能则尚不完全明确。<sup><a href=\"#quote_3\" class=\"kx_ref\">[3]</a></sup>HIF-1α和HIF-2α与HIF-β（ARNT）类似，都属于碱性螺旋-环-螺旋蛋白（basic Helix-Loop-Helix, bHLH）家族中的PAS（Per-Arnt-Sim）亚科，且都包含以下几个结构域<sup><a href=\"#quote_2\" class=\"kx_ref\">[2]</a></sup><sup><a href=\"#quote_3\" class=\"kx_ref\">[3]</a></sup>：<br></p><ol>\n <li><p>bHLH结构域：负责与DNA结合</p></li>\n <li><p>PAS结构域：负责形成二聚体</p></li>\n <li><p>C-末端激活结构域（C-Terminal Activation Domain, CTAD）：负责招募转录调节因子</p></li>\n <li><p>N-末端激活结构域（N-Terminal Activation Domain, NTAD）：可能与靶基因结合特异性有关</p></li>\n</ol><p>除此之外，HIF的α亚基还包含一段“氧气依赖性降解结构域”（Oxygen-dependent Degradation Domain，ODD）。</p><p>2015年，Wu等利用X射线晶体衍射解析了第一组HIF-α-ARNT复合物的三维结构，并解析了HIF复合物与缺氧反应元件（Hypoxia Response Element, HRE）的DNA结合后的三维结构。<sup><a href=\"#quote_3\" class=\"kx_ref\">[3]</a></sup>通过该结构，研究人员发现HIF的α亚基和β亚基（ARNT）以一种非对称的方式形成二聚体，在与DNA结合时，HIF-α-ARNT复合物的构象发生变化，从而使bHLH结构域与HRE的DNA序列接触。<sup><a href=\"#quote_3\" class=\"kx_ref\">[3]</a></sup><sup><a href=\"#quote_4\" class=\"kx_ref\">[4]</a></sup>该结构还验证了几个癌症相关的HIF突变位点及其对HIF的影响。<sup><a href=\"#quote_3\" class=\"kx_ref\">[3]</a></sup><sup><a href=\"#quote_4\" class=\"kx_ref\">[4]</a></sup>通过对HIF-α-ARNT和小分子共结晶，他们还发现了几个潜在的药物分子结合位点，为调节HIF活性的药物开发提供了理论指导。<sup><a href=\"#quote_3\" class=\"kx_ref\">[3]</a></sup><sup><a href=\"#quote_4\" class=\"kx_ref\">[4]</a></sup></p><p><img class=\"kx_img ed_imgfloat_right\" width=\"232\" height=\"174\" titlename=\"HIF-α-ARNT复合物未结合DNA (a) 以及结合DNA后 (b) 的结构示意图\" bigsrc=\"https://img02.sogoucdn.com/app/a/200698/895_481_20200108072031-981941481.png\" data-src=\"https://img02.sogoucdn.com/app/a/200698/895_481_20200108072031-981941481.png\"></p>","pics":[{"originalUrl":"https://web.archive.org/web/20221028221515/https://img02.sogoucdn.com/app/a/200698/895_481_20200108072031-981941481.png?w=895&h=481&titlename=HIF-%25CE%25B1-ARNT%25E5%25A4%258D%25E5%2590%2588%25E7%2589%25A9%25E6%259C%25AA%25E7%25BB%2593%25E5%2590%2588DNA%2520%2528a%2529%2520%25E4%25BB%25A5%25E5%258F%258A%25E7%25BB%2593%25E5%2590%2588DNA%25E5%2590%258E%2520%2528b%2529%2520%25E7%259A%2584%25E7%25BB%2593%25E6%259E%2584%25E7%25A4%25BA%25E6%2584%258F%25E5%259B%25BE","url":"https://web.archive.org/web/20221028221515/https://img02.sogoucdn.com/app/a/200698/895_481_20200108072031-981941481.png","rw":895,"rh":481,"title":"HIF-%CE%B1-ARNT%E5%A4%8D%E5%90%88%E7%89%A9%E6%9C%AA%E7%BB%93%E5%90%88DNA%20%28a%29%20%E4%BB%A5%E5%8F%8A%E7%BB%93%E5%90%88DNA%E5%90%8E%20%28b%29%20%E7%9A%84%E7%BB%93%E6%9E%84%E7%A4%BA%E6%84%8F%E5%9B%BE","alt":null,"width":0,"height":0}],"card":null,"references":[],"versionCount":0},{"paragraphId":"20039536927059715","title":"缺氧调控的信号通路","versionId":"21206855502016011","lemmaId":18154930745377030,"createType":0,"creator":{"uid":0,"name":null,"pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"createTime":0,"versionEditor":{"uid":77532282,"name":"胡天楠","pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"editTime":1579936270,"comment":null,"dependVersionId":0,"contentType":1,"content":"<p>在正常氧分压下，脯氨酸羟化酶（prolyl hydroxylase domain-containing protein, PHD）可以催化HIF-1α的ODD结构域中的两个脯氨酸与氧气反应，发生羟基化。HIF-1α羟基化后，可以被另一种叫做VHL的蛋白（von Hippel-Lindau tumour suppressor protein）识别。VHL具有泛素化连接酶（ubiquitin ligase）活性，识别HIF-1α之后会为其打上泛素（ubiquitin）的“分子标签”。被打上泛素标签的蛋白质会被转运到蛋白酶体（proteasome）降解掉。因此，在正常氧分压下，HIF-1α迅速被降解，其半衰期很短，几乎不能被检测到。<sup><a href=\"#quote_5\" class=\"kx_ref\">[5]</a></sup><sup><a href=\"#quote_6\" class=\"kx_ref\">[6]</a></sup></p><p><img class=\"kx_img ed_imgfloat_right currentPic\" width=\"232\" height=\"174\" titlename=\"\" bigsrc=\"https://img04.sogoucdn.com/app/a/200698/3508_2480_20200111031755-1724776499.png\" data-src=\"https://img04.sogoucdn.com/app/a/200698/3508_2480_20200111031755-1724776499.png\"></p><p>由于氧气是脯氨酸羟化反应中的底物，在缺氧条件下，HIF-1α的脯氨酸不能被羟化，故而可以稳定存在。在细胞核输入蛋白（importin）的介导下，HIF-1α转运至细胞核中，并与那里的HIF-β结合，并招募其他转录调节因子如P300/CBP （CREB binding protein）形成活性复合体。该复合体继而与靶基因的缺氧反应元件（HRE）结合，从而激活一系列下游基因的转录。<sup><a href=\"#quote_6\" class=\"kx_ref\">[6]</a></sup></p><p>受HIF调控的下游基因包括促红细胞生成素（erythropoietin, EPO），血管内皮生长因子（vascular endothelial growth factor, VEGF），控制糖酵解的基因等。<sup><a href=\"#quote_7\" class=\"kx_ref\">[7]</a></sup>这些基因从不同角度提高机体对低氧环境的适应能力，例如EPO可以促进携氧的红细胞生成，VEGF可以促进血管生长，糖酵解可以解决缺氧环境下细胞的能量来源。可见，缺氧诱导因子处于缺氧调控信号通路的中心环节，起着牵一发而动全身的作用。<br></p>","pics":[{"originalUrl":"https://web.archive.org/web/20221028221515/https://img04.sogoucdn.com/app/a/200698/3508_2480_20200111031755-1724776499.png?w=3508&h=2480","url":"https://web.archive.org/web/20221028221515/https://img04.sogoucdn.com/app/a/200698/3508_2480_20200111031755-1724776499.png","rw":3508,"rh":2480,"title":"","alt":null,"width":0,"height":0}],"card":null,"references":[],"versionCount":0},{"paragraphId":"20039536927059716","title":"缺氧诱导因子与海洋哺乳动物的缺氧适应","versionId":"20039536910282516","lemmaId":18154930745377030,"createType":0,"creator":{"uid":0,"name":null,"pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"createTime":0,"versionEditor":{"uid":77532282,"name":"胡天楠","pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"editTime":1579240494,"comment":null,"dependVersionId":0,"contentType":1,"content":"<p>作为缺氧调控信号通路的中心环节，缺氧诱导因子在海洋哺乳动物的缺氧适应中有着重要作用。不同于鱼类，海洋哺乳动物（如海豹、海豚和鲸类）在水下活动时主要靠屏息潜水。这对海洋哺乳动物的缺氧耐受能力是一个很大的挑战。为了应对这一环境压力，海洋哺乳动物进化出了一系列机制。一方面，海洋哺乳动物的身体可以更多地储存氧气，另一方面，海洋哺乳动物可以更好地对缺氧/有氧的剧烈变化做出反应，调整代谢通路，从而避免缺氧带来的供能不足和有氧带来的氧化损伤。<sup><a href=\"#quote_8\" class=\"kx_ref\">[8]</a></sup></p><p>对HIF-1α的进化分析表明，在许多耐受缺氧环境的哺乳动物中，HIF-1α的氨基酸序列存在趋同进化的现象，这提示HIF-1α的进化参与了哺乳动物的缺氧适应。<sup><a href=\"#quote_9\" class=\"kx_ref\">[9]</a></sup>不同于人体，在海豹体内的一些组织中，HIF-1α可以在常氧下稳定存在。<sup><a href=\"#quote_10\" class=\"kx_ref\">[10]</a></sup>进一步研究表明，HIF-1α在海豹的肺部组织中表达最高，而在心肌组织中表达较低。<sup><a href=\"#quote_10\" class=\"kx_ref\">[10]</a></sup><sup><a href=\"#quote_11\" class=\"kx_ref\">[11]</a></sup>由于肺部面临着氧分压的剧烈变化，海豹肺部组织中的HIF-1α在常氧下稳定表达可以起到“预适应”的效果，从而避免了缺氧/有氧循环时的氧化损伤，而海豹肺部组织中被氧化蛋白含量较低也佐证了这一观点。<sup><a href=\"#quote_11\" class=\"kx_ref\">[11]</a></sup></p><p>对海豹HIF-1α的基因拷贝数和序列分析表明，海豹体内HIF-1α的稳定存在可能并非是由于HIF-1α基因本身发生突变导致的。<sup><a href=\"#quote_10\" class=\"kx_ref\">[10]</a></sup><sup><a href=\"#quote_11\" class=\"kx_ref\">[11]</a></sup>一种可能的机制是，海豹体内还原性的谷胱甘肽含量较高，从而阻止了HIF-1α在常氧下发生脯氨酸羟化反应。<sup><a href=\"#quote_12\" class=\"kx_ref\">[12]</a></sup><sup><a href=\"#quote_13\" class=\"kx_ref\">[13]</a></sup></p>","pics":null,"card":null,"references":[],"versionCount":0},{"paragraphId":"20039536943836941","title":"缺氧诱导因子与人类疾病","versionId":"21206855502016012","lemmaId":18154930745377030,"createType":0,"creator":{"uid":0,"name":null,"pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"createTime":0,"versionEditor":{"uid":77532282,"name":"胡天楠","pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"editTime":1579936270,"comment":null,"dependVersionId":0,"contentType":1,"content":"<h3>恶性肿瘤</h3><p>恶性肿瘤能摆脱机体控制无限增殖，在肿瘤细胞增殖过程中，往往处于缺氧微环境。近年来研究发现低氧可诱导癌细胞产生缺氧诱导因子。HIF在肿瘤适应缺氧环境、帮助肿瘤侵袭转移及对放化疗产生耐药性方面都起到重要作用。<sup><a href=\"#quote_14\" class=\"kx_ref\">[14]</a></sup></p><p>在HIF调控的下游基因里，有4类表达产物对肿瘤细胞适应缺氧微环境、侵袭、转移相关<sup><a href=\"#quote_14\" class=\"kx_ref\">[14]</a></sup>：</p><ol>\n <li><p>血管、淋巴管生成相关基因：主要包括血管内皮生长因子（VEGF）、血管生成素样蛋白（ANGPTL）、淋巴管内皮生长因子（VEGF-C）等。这些基因在HIF活化下表达，促进肿瘤附近血管和淋巴管生成，缓解肿瘤细胞缺氧程度，促进癌细胞沿血管或淋巴管转移。</p></li>\n <li><p>葡萄糖转运与糖酵解酶：包括乳酸脱氢酶A（LDHA）、丙酮酸脱氢酶激酶-1（PDK-1）等。这些酶表达上调促进肿瘤细胞进行无氧呼吸，缓解了缺氧微环境中的能量危机，帮助肿瘤细胞持续生长。</p></li>\n <li><p>肿瘤增殖和凋亡相关蛋白：研究表明癌细胞中HIF可以上调“含Caspase招募域的凋亡抑制蛋白”（apoptosis &nbsp;repressor &nbsp;with &nbsp;caspase &nbsp;recruitment &nbsp;domain，ARC）表达。ARC可抑制p53等多种凋亡相关基因的活性，干扰内外源死亡途径，使肿瘤细胞存活，增强肿瘤细胞对放化疗的抵抗力。</p></li>\n <li><p>促进上皮间质转化（epithelial &nbsp;mesenchymal &nbsp;transition，EMT）及细胞外基质降解相关因子：HIF诱导肿瘤细胞获得间叶源性表型特征，介导肿瘤细胞上皮间质转化。上皮间质转化是许多上皮系统肿瘤恶变的第一步。HIF还可促进基质金属蛋白酶（MMP）的表达，MMP协同降解细胞外基质（extracellular &nbsp;matrix，ECM），调控肿瘤细胞与ECM连接，在肿瘤侵袭转移中起到关键作用。</p></li>\n</ol><h3>缺血性中风</h3><p>缺血性中风，又称脑梗塞，是中风里最常见的一种类型。<sup><a href=\"#quote_15\" class=\"kx_ref\">[15]</a></sup>缺血性中风导致脑部缺血缺氧，由于成年人的神经细胞无法再生，故而往往产生永久性的后遗症。许多证据表明，在缺血性中风的过程中，缺氧诱导因子HIF-1α都会出现明显上调。<sup><a href=\"#quote_16\" class=\"kx_ref\">[16]</a></sup>大部分研究认为，HIF-1α的上调是一种保护机制。这种保护机制主要通过以下几个方面实现<sup><a href=\"#quote_16\" class=\"kx_ref\">[16]</a></sup><sup><a href=\"#quote_17\" class=\"kx_ref\">[17]</a></sup>：<br></p><ol>\n <li><p>HIF-1α可提高促红细胞生成素（EPO）的表达，EPO被认为有神经保护作用</p></li>\n <li><p>HIF-1α可提高血管生长因子（VEGF）的表达，VEGF可以促进新生血管生长，改善微循环，促进组织血液供应。</p></li>\n <li><p>HIF-1α可阻止细胞凋亡相关通路，促进细胞存活。</p></li>\n</ol><p>然而，也有部分研究认为，HIF-1α的上调也可能在某些情况下产生不利影响。在一些中风损伤模型中，HIF-1α上调可导致p53表达上调，从而诱导细胞的延迟死亡。<sup><a href=\"#quote_16\" class=\"kx_ref\">[16]</a></sup>另外，HIF-1α在小胶质细胞中可促进炎症相关因子的表达，这也会加剧中风后的细胞损伤。<sup><a href=\"#quote_17\" class=\"kx_ref\">[17]</a></sup>总之，HIF-1α对神经系统的作用可能因中风缺血缺氧时间长短、以及不同类型的脑细胞而产生不同影响。<sup><a href=\"#quote_16\" class=\"kx_ref\">[16]</a></sup><sup><a href=\"#quote_17\" class=\"kx_ref\">[17]</a></sup></p><h3>冠心病</h3><p>冠心病的本质是冠状动脉粥样硬化导致的心肌缺血。与缺血性中风类似，HIF被普遍认为对缺血性心脏病有保护性作用。<sup><a href=\"#quote_18\" class=\"kx_ref\">[18]</a></sup>HIF缺陷的实验小鼠对心肌梗塞的耐受能力更差。<sup><a href=\"#quote_18\" class=\"kx_ref\">[18]</a></sup>HIF对缺血心肌的保护机制与对脑卒中后神经组织的保护机制类似，都涉及促进新生血管生成、改变代谢通路以促进细胞存活等。另外，HIF还可以激活产生腺苷的基因，而腺苷被认为与心肌缺血的预适应有关。<sup><a href=\"#quote_18\" class=\"kx_ref\">[18]</a></sup></p><h3>其他疾病</h3><p>缺氧诱导因子被认为在肺动脉高压的病理过程中有着重要作用。一系列主宰肺动脉平滑肌的缺氧改变的基因受HIF调控。在实验小鼠中，HIF-1α或HIF-2α基因缺失可以保护小鼠免于患上缺氧性肺动脉高压。这说明HIF对肺动脉高压的发生有促进作用。<sup><a href=\"#quote_18\" class=\"kx_ref\">[18]</a></sup></p><p>家族性红细胞增多症是具有遗传性的基因病，其特征表现为红细胞数增加。VHL、PHD2和HIF-2α的基因突变均可导致本病发生。<sup><a href=\"#quote_18\" class=\"kx_ref\">[18]</a></sup>这主要因为促红细胞生成素（EPO）是受HIF调控的，而任何基因突变导致的HIF通路上调都会增加EPO的表达，从而导致过多的红细胞生成。基于以上原理，现在已经开发出基因检测用以诊断这种罕见的遗传病。<sup><a href=\"#quote_19\" class=\"kx_ref\">[19]</a></sup></p>","pics":null,"card":null,"references":[],"versionCount":0},{"paragraphId":"20039536943836942","title":"缺氧诱导因子相关的药物研发","versionId":"20039536910282518","lemmaId":18154930745377030,"createType":0,"creator":{"uid":0,"name":null,"pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"createTime":0,"versionEditor":{"uid":77532282,"name":"胡天楠","pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"editTime":1579240494,"comment":null,"dependVersionId":0,"contentType":1,"content":"<p>由于HIF对恶性肿瘤的促进作用，抑制HIF通路是一种抗癌的潜在途径。许多现有的化疗药物（如拓扑替康、依维莫司）可以间接地抑制HIF的活性，虽然这可能并非其主要的抗癌机理。直接通过抑制HIF通路来实现化疗作用的分子目前尚处于临床实验阶段，其机理包括抑制HIF的mRNA合成、抑制HIF的α亚基和β亚基结合、抑制HIF与DNA结合等。<sup><a href=\"#quote_20\" class=\"kx_ref\">[20]</a></sup><sup><a href=\"#quote_21\" class=\"kx_ref\">[21]</a></sup></p><p>在HIF-1α的降解过程的第一步，脯氨酸羟化酶（PHD）起到了关键的作用，故而，提高HIF通路可以通过抑制PHD得以实现。通过抑制PHD来提高HIF-1α活性，理论上可以对许多缺血性疾病起到治疗作用，这些疾病包括中风<sup><a href=\"#quote_22\" class=\"kx_ref\">[22]</a></sup>、冠心病<sup><a href=\"#quote_23\" class=\"kx_ref\">[23]</a></sup>、贫血等。目前，用于治疗慢性肾病导致的贫血的PHD抑制剂已进入临床III期研究。<sup><a href=\"#quote_24\" class=\"kx_ref\">[24]</a></sup></p><p>另外，有研究表明，在动物实验中，抑制PHD的活性可以大幅提高实验动物对无氧环境的耐受能力。<sup><a href=\"#quote_25\" class=\"kx_ref\">[25]</a></sup>相比正常小鼠，运动训练对PHD2缺陷的小鼠效果更佳。<sup><a href=\"#quote_26\" class=\"kx_ref\">[26]</a></sup>这意味着PHD抑制剂有潜力作为辅助药物，用以提高运动员（尤其是长跑、游泳、自由潜水等）在无氧条件下的表现。</p>","pics":null,"card":null,"references":[],"versionCount":0}],"references":[{"id":1,"type":"web","title":"The Nobel Prize in Physiology or Medicine 2019.","site":"Nobel Prize Official Website","url":"https://web.archive.org/web/20221028221515/https://www.nobelprize.org/prizes/medicine/2019/summary/","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":2,"type":"web","title":"Hypoxia Inducible Factor (HIF) transcription factor family expansion, diversification, divergence and selection in eukaryotes.","site":"NCBI","url":"https://web.archive.org/web/20221028221515/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5470732/","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":3,"type":"web","title":"Oxygen Sensing by Metazoans: The Central Role of the HIF Hydroxylase Pathway.","site":"Molecular Cell","url":"https://web.archive.org/web/20221028221515/https://www.cell.com/molecular-cell/references/S1097-2765(08)00292-X","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":4,"type":"web","title":"Hypoxia response becomes crystal clear.","site":"Nature","url":"https://web.archive.org/web/20221028221515/https://www.nature.com/articles/nature14641","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":5,"type":"web","title":"Press release: The Nobel Prize in Physiology or Medicine 2019.","site":"Nobel prize official website","url":"https://web.archive.org/web/20221028221515/https://www.nobelprize.org/prizes/medicine/2019/press-release/","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":6,"type":"web","title":"低氧诱导因子-1的调节。","site":"Chinese Bulletin of Life Sciences","url":"https://web.archive.org/web/20221028221515/http://www.lifescience.net.cn/news/upload/2013140.pdf","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":7,"type":"web","title":"Targeted genes and interacting proteins of hypoxia inducible factor-1.","site":"NCBI","url":"https://web.archive.org/web/20221028221515/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3388736/?report=classic","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":8,"type":"web","title":"Natural Tolerance to Ischemia and Hypoxemia in Diving Mammals: A Review.","site":"Frontiers in Physiology","url":"https://web.archive.org/web/20221028221515/https://www.frontiersin.org/articles/10.3389/fphys.2019.01199/full","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":9,"type":"web","title":"Evolutionary Genetics of Hypoxia and Cold Tolerance in Mammals.","site":"Journal of Molecular Evolution","url":"https://web.archive.org/web/20221028221515/https://link.springer.com/article/10.1007/s00239-018-9870-8","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":10,"type":"web","title":"Hypoxia-inducible factor 1 proteomics and diving adaptations in ringed seal.","site":"Free Radical Biology and Medicine","url":"https://web.archive.org/web/20221028221515/https://www.sciencedirect.com/science/article/abs/pii/S0891584905001346?via%3Dihub","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":11,"type":"web","title":"Hypoxia-Inducible Factor in Ringed Seal (Phoca hispida) Tissues.","site":"Free Radical Research","url":"https://web.archive.org/web/20221028221515/https://www.tandfonline.com/doi/abs/10.1080/10715760410001725526","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":12,"type":"web","title":"Glutathione protection against dive-associated ischemia/reperfusion in ringed seal tissues.","site":"Journal of Experimental Marine Biology and Ecology","url":"https://web.archive.org/web/20221028221515/https://www.sciencedirect.com/science/article/pii/S0022098107000950","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":13,"type":"web","title":"Ischemia/Reperfusion in Diving Birds and Mammals: How They Avoid Oxidative Damage.","site":"Academia.edu","url":"https://web.archive.org/web/20221028221515/https://www.academia.edu/10363650/Ischemia_Reperfusion_in_Diving_Birds_and_Mammals_How_They_Avoid_Oxidative_Damage","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":14,"type":"web","title":"HIF-1表达在肿瘤生长及演进中的作用。","site":"国际病理科学与临床杂志","url":"https://web.archive.org/web/20221028221515/http://www.cnki.com.cn/Article/CJFDTotal-WYSB201302013.htm","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":15,"type":"web","title":"Types of Stroke.","site":"American Stroke Association","url":"https://web.archive.org/web/20221028221515/https://www.stroke.org/en/about-stroke/types-of-stroke","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":16,"type":"web","title":"Hypoxia Inducible Factor 1 as a Therapeutic Target in Ischemic Stroke.","site":"NCBI","url":"https://web.archive.org/web/20221028221515/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2819104/","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":17,"type":"web","title":"Hypoxia Inducible Factor-1: Its Potential Role In Cerebral Ischemia.","site":"Cellular and Molecular Neurobiology","url":"https://web.archive.org/web/20221028221515/https://link.springer.com/article/10.1007/s10571-012-9803-9#Sec20","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":18,"type":"web","title":"Hypoxia-Inducible Factors in Physiology and Medicine.","site":"Cell","url":"https://web.archive.org/web/20221028221515/https://www.cell.com/fulltext/S0092-8674(12)00087-6","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":19,"type":"web","title":"红细胞增多症基因检测。","site":"知乎专栏","url":"https://web.archive.org/web/20221028221515/https://zhuanlan.zhihu.com/p/31380266","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":20,"type":"web","title":"Development of Inhibitors Targeting Hypoxia-Inducible Factor 1 and 2 for Cancer Therapy.","site":"NCBI","url":"https://web.archive.org/web/20221028221515/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5368132/","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":21,"type":"web","title":"HIF Inhibitors: Status of Current Clinical Development.","site":"Current Oncology Reports","url":"https://web.archive.org/web/20221028221515/https://link.springer.com/article/10.1007%2Fs11912-019-0752-z#Sec13","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":22,"type":"web","title":"Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibition: Robust New Target or Another Big Bust for Stroke Therapeutics?","site":"Journal of Cerebral Blood Flow &amp; Metabolism","url":"https://web.archive.org/web/20221028221515/https://journals.sagepub.com/doi/full/10.1038/jcbfm.2012.28","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":23,"type":"web","title":"Chronic Inhibition of Hypoxia-inducible Factor Prolyl 4-hydroxylase Improves Ventricular Performance, Remodeling, and Vascularity After Myocardial Infarction in the Rat.","site":"Journal of Cardiovascular Pharmacology","url":"https://web.archive.org/web/20221028221515/https://journals.lww.com/cardiovascularpharm/Fulltext/2010/08000/Chronic_Inhibition_of_Hypoxia_inducible_Factor.5.aspx?casa_token=SFxiXNINKJgAAAAA:RWQbpvGfwbA9ruAu85Ip_Ia4xwex4bEpC-sPwDUkbXlwebPV813xbAuesSHTNEDwzMUD_QeTQiMYolUJ3bCDZ79o","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":24,"type":"web","title":"Discovery and Preclinical Characterization of GSK1278863 (Daprodustat), a Small Molecule Hypoxia Inducible Factor–Prolyl Hydroxylase Inhibitor for Anemia.","site":"Journal of Pharmacology and Experimental Therapeutics","url":"https://web.archive.org/web/20221028221515/http://jpet.aspetjournals.org/content/363/3/336","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":25,"type":"web","title":"Prolyl hydroxylase inhibitor treatment confers whole‐animal hypoxia tolerance.","site":"Acta Physiologica","url":"https://web.archive.org/web/20221028221515/https://onlinelibrary.wiley.com/doi/full/10.1111/j.1748-1716.2007.01676.x?casa_token=gsCX3JljbJQAAAAA%3A9kkLuaCGsxVF0QIgh_rJyG2o8Py2O4GKiZxq_P_Wz0ciYuMAKTQbRmAc5slTg1kohE7viw850IOGN1o","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":26,"type":"web","title":"Activation of the hypoxia‐inducible factor pathway induced by prolyl hydroxylase domain 2 deficiency enhances the effect of running training in mice.","site":"Acta Physiologica","url":"https://web.archive.org/web/20221028221515/https://onlinelibrary.wiley.com/doi/full/10.1111/apha.12751","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false}],"recommendReferences":null,"auditState":2,"lemmaLevel":1,"origin":0,"originEnTitle":null,"originZhTitle":null,"pv":771,"auditType":0,"synonyms":null,"showEditTime":"2020.01.25 15:11","auditors":[{"uid":75234227,"name":"7","pic":"https://web.archive.org/web/20221028221515/https://cache.soso.com/qlogo/g?b=oidb&k=plvPjjqaNicMYKMwhI6yKUA&s=100&t=1555919297","introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":"","jobBrief":"","role":0,"roleName":null,"title":"","professionalTitle":null,"phoneNo":null,"editable":true,"partnerId":177,"partnerIdCreateTime":1595844898,"partnerIdPoped":true}],"hasZhishiNav":false,"auditInfos":{"0":[{"versionId":"0","auditTime":1579941625,"auditorId":75234227,"auditUser":{"uid":75234227,"name":"7","pic":"https://web.archive.org/web/20221028221515/https://cache.soso.com/qlogo/g?b=oidb&k=plvPjjqaNicMYKMwhI6yKUA&s=100&t=1555919297","introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":"","jobBrief":"","role":0,"roleName":null,"title":"","professionalTitle":null,"phoneNo":null,"editable":true,"partnerId":177,"partnerIdCreateTime":1595844898,"partnerIdPoped":true},"auditReason":"已通过","auditSuggest":null,"auditResult":2,"auditAnnotations":null}]},"isHistory":false};</script><script crossorigin="anonymous" src="./d18154930745377030.缺氧诱导因子 - 搜狗科学百科_files/aegis.min.js.download"></script><script crossorigin="anonymous" src="./d18154930745377030.缺氧诱导因子 - 搜狗科学百科_files/main_2020092401.js.download"></script><script crossorigin="anonymous" src="./d18154930745377030.缺氧诱导因子 - 搜狗科学百科_files/react.production.min.js.download"></script><script crossorigin="anonymous" src="./d18154930745377030.缺氧诱导因子 - 搜狗科学百科_files/react-dom.production.min.js.download"></script><script crossorigin="anonymous" src="./d18154930745377030.缺氧诱导因子 - 搜狗科学百科_files/jquery-1.11.1.min.js.download"></script><script crossorigin="anonymous" src="./d18154930745377030.缺氧诱导因子 - 搜狗科学百科_files/main_2022062701.js.download"></script><script crossorigin="anonymous" src="./d18154930745377030.缺氧诱导因子 - 搜狗科学百科_files/main_66bbe21.js.download"></script><script crossorigin="anonymous" src="./d18154930745377030.缺氧诱导因子 - 搜狗科学百科_files/react.production.min.js.download"></script><script crossorigin="anonymous" src="./d18154930745377030.缺氧诱导因子 - 搜狗科学百科_files/react-dom.production.min.js.download"></script><script crossorigin="anonymous" src="./d18154930745377030.缺氧诱导因子 - 搜狗科学百科_files/main_edf0f08.js.download"></script>
</body></html>